date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2018-01-17 13:01:06.393,292.67,294.0,287.58,291.0,177876.0,Ipca Laboratories buys US API developer Pisgah Labs for $9.65 million,Ipca Laboratories says Ipca Pharmaceutical USA and Onyx Scientific UK acquires 100% share capital of Pisgah Labs for $9.65 million free of debt,neutral,neutral,-0.5706085352103105,neutral,-0.603448275862069,neutral
2018-02-07 18:01:35.241,289.75,301.8,289.5,294.6,2155344.0,"Fiberweb, Ipca Lab rise 9-16% on strong Q3 numbers",Ipca Laboratories has posted 155 percent rise in its Q3 net profit at Rs 105.6 crore against Rs 41.4 crore in a year ago period.,positive,positive,1.6738567730802494,positive,6.994818652849741,positive
2018-02-09 13:00:13.532,289.5,313.65,288.55,309.75,3785826.0,IPCA Labs: Eyes on FDA officials visit,"The US FDA could re-inspect the three facilities of Ipca Laboratories that are under the regulator’s import alert, in September. In the first half of the next fiscal there could be an inspection but i",neutral,neutral,6.994818652849741,positive,1.1111111111111112,positive
2018-02-09 18:00:51.801,289.5,313.65,288.55,309.75,3785826.0,23 stocks from BSE500 gain over 10% during current week in weak market,"FDC, SpiceJet, SAIL, Bharat Forge, Ipca Laboratories, Jet Airways and Bajaj Electricals are among 23 stocks from the S&P BSE500 index gaining an over 10% during current week in otherwise weak market",positive,positive,6.994818652849741,positive,1.1111111111111112,positive
2018-02-23 13:01:15.813,334.25,344.5,332.67,338.0,1514342.0,Ipca Laboratories (₹662.7),"The stock of Ipca Laboratories gained 3.7 per cent with good volume on Thursday. During the rally, the stock broke above a key long-term resistance at ₹640. The jump has given investors/traders an opp",neutral,positive,1.1219147344801794,positive,0.1130952380952367,neutral
2018-04-17 13:01:44.483,358.5,358.5,350.15,355.0,341230.0,IPCA Laboratories Q4 PAT seen up 209.3% YoY to Rs. 83.8 cr: Edelweiss,"Net Sales are expected to increase by 19.4 percent Y-o-Y (down 7.5 percent Q-o-Q) to Rs. 795.1 crore, according to Edelweiss.",positive,positive,-0.9762900976290098,negative,-2.266479663394105,negative
2018-08-09 13:02:07.863,375.1,379.2,367.58,370.0,494972.0,"D-Street Buzz: Pharma, PSU Bank stocks gain; Selan Exploration hits 52-week high","Bajaj Finance, IPCA Laboratories, Torrent Pharmaceuticals, Info Edge, Nelco, Selan Exploration, VIP Industries are some of the stocks which have hit new 52-week high in the morning trade on NSE.",positive,neutral,-1.3596374300186678,negative,0.0136054421768738,neutral
2018-08-09 18:00:50.783,375.1,379.2,367.58,370.0,494972.0,Ipca Labs Q1 net profit at Rs 65 cr on strong sales,"Ipca Laboratories today reported a standalone net profit of Rs 65.52 crore for the quarter ended June 30, mainly on account of robust sales. The drug firm had posted a net loss of Rs 20.25 crore in th",positive,negative,-1.3596374300186678,negative,0.0136054421768738,neutral
2018-10-03 13:00:58.307,328.42,329.55,316.3,320.5,129444.0,Ipca Labs arm acquires 80% stake in US-based Bayshore Pharmaceuticals for $10.28 mn,Pharmaceutical firm Ipca Laboratories on Wednesday announced the acquisition of 80 per cent stake in US’ Bayshore Pharmaceuticals LLC by its subsidiary for $10.286 million (approx Rs 75.4 crore).The a,neutral,neutral,-2.411546190853181,negative,-0.4672897196261681,neutral
2018-11-20 13:00:38.249,372.4,381.9,371.8,380.05,198872.0,Nomura raises price target for IPCA Lab,Nomura has raised the price target for shares of drugmaker IPCA Laboratories Ltd to Rs 915 from Rs 723.The stock is quoted flat at 761.45 today on the NSE.Brokerage house expects its earnings growth t,positive,positive,2.054242749731481,positive,4.230597739134995,positive
2019-02-12 18:01:32.922,375.0,378.5,370.05,375.5,781026.0,Ipca Laboratories Q3 net jumps 52% to Rs 160.18 cr,"Drug firm Ipca Laboratories on Tuesday posted a 52 per cent jump in its net profit at Rs 160.18 crore for the third quarter ended December 31, 2018. The company had posted a net profit of Rs 105.58 cr",positive,positive,0.1333333333333333,neutral,0.5099872503187312,neutral
2019-02-18 10:01:58.409,394.0,414.42,388.02,402.0,781892.0,Nomura raises Ipca Labs price target on hope of strong earnings growth ahead,"Japanese brokerage house Nomura has retained its buy call on Ipca Laboratories and raised price target to Rs 1,005 from Rs 915 apiece after revising earnings growth estimates upward.",positive,positive,2.030456852791878,positive,0.3911665676371519,neutral
2019-03-29 10:00:58.710,482.5,523.0,480.0,489.0,1431048.0,"D-Street Buzz: Nifty Energy outperforms led by HPCL; Vodafone Idea jumps 10%, Tata Motors gains","ICICI Bank, Future Lifestyle Fashions, DCB Bank, IDFC First Bank, IPCA Laboratories, Mahanagar Gas, Muthoot Finance, Oriental Bank of Commerce and Varun Beverages have hit 52-week high on NSE.",positive,neutral,1.3471502590673576,positive,-1.2558233745189364,negative
2019-04-24 23:01:05.947,488.5,493.8,487.85,489.5,285716.0,Ipca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 cr,"The company has entered into a share purchase agreement (SPA) to acquire 100 per cent paid-up share capital of Ramdev Chemical Pvt Ltd (RCPL), Ipca Laboratories said in a regulatory filing.

",positive,positive,0.2047082906857728,neutral,-1.3221620517012418,negative
2019-07-12 18:01:20.366,474.35,482.0,474.25,479.35,78884.0,IPCA Laboratories Q1 PAT seen up 34.1% YoY to Rs. 87.9 cr: Prabhudas Lilladher,"Net Sales are expected to increase by 14 percent Y-o-Y (up 16.8 percent Q-o-Q) to Rs. 973.5 crore, according to Prabhudas Lilladher.",positive,positive,1.054073995994519,positive,-1.1357512953367912,negative
2019-09-26 10:04:09.201,469.45,471.5,445.65,455.0,690788.0,"Board Meetings Today: PNB, Fortis Healthcare, IPCA Labs, Engineers India and Relaxo Footwears",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,-3.078070082010861,negative,0.6213888586067857,neutral
2019-10-14 18:02:46.841,443.12,445.0,430.55,439.0,861138.0,Ipca Labs Q2 PAT seen up 34% YoY to Rs. 160.2 cr: Emkay,"Net Sales are expected to increase by 12.8 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 1,125.4 crore, according to Emkay.",positive,positive,-0.929770716735874,negative,1.0735676347609902,positive
2019-11-07 18:00:51.648,532.92,547.5,527.5,536.95,1621350.0,Ipca Labratories Q2 net up 63.27% at Rs 193.54 crore,The company had posted a consolidated net profit of Rs 118.54 crore in the same period last fiscal.,positive,positive,0.7562110635742864,neutral,2.910798122065728,positive
2019-11-26 10:00:45.246,551.03,562.2,535.0,561.22,1399916.0,Ipca Labs' Piparia unit classified as Official Action Indicated by USFDA; stock flat,"“Since this manufacturing facility is already under USFDA import alert and presently not doing any US business, this will have no impact on Company's current on-going business activities,” the company said.",neutral,neutral,1.84926410540262,positive,0.0357538703564742,neutral
2019-11-26 18:00:42.636,559.38,568.17,550.0,559.58,141046.0,US health regulator finds Silvassa unit non-compliant with CGMP: Ipca Labs,"The company said that since this manufacturing facility is already under USFDA import alert and presently not doing any US business, this will have no impact on company's current on-going business activities. The USFDA inspection of its Piparia (Silvassa) formulations manufacturing unit in August resulted in three observations.",neutral,neutral,0.0357538703564742,neutral,-0.4912654074665216,neutral
2019-12-03 10:00:40.538,560.75,572.5,558.0,571.17,141064.0,Strong domestic and export growth to drive Ipca Laboratories' earnings,Ipca's first half performance holds testimony to its robust growth with India business growing in mid-teens,positive,positive,1.858225590726698,positive,-1.438334669967572,negative
2019-12-11 13:02:32.076,571.5,580.0,558.65,562.5,1352768.0,IPCA Lab advances 3% on strong fundamentals,"Shares of Ipca Laboratories rose today after a fall from a month high of Rs 1,161, as seen on charts, on November 18 this year. The stock gained nearly 3% to Rs 1,093.50 on the BSE with volumes of 1,7",positive,positive,-1.574803149606299,negative,0.5595026642983973,neutral
2019-12-20 18:03:38.962,569.45,572.47,564.45,565.0,226830.0,Ipca Labs partners with MMV to co-develop novel antimalarial co-formulation,"Atoguanil, based on proprietary Ipca technology, contains the active pharmaceutical ingredients atovaquone and proguanil.",positive,neutral,-0.7814557906752208,neutral,-0.4492996211787428,neutral
2019-12-26 23:02:29.373,577.5,577.5,566.35,570.5,224394.0,Here's how Ipca Laboratories turned the tide and emerged as investor favourite,"Ipca, which was growing at frantic pace in the first half of this decade, lost steam in the middle due to regulatory woes.",positive,negative,-1.2121212121212122,negative,-0.7611548556430486,neutral
2020-01-14 10:04:59.684,597.5,617.0,594.58,608.35,315504.0,"Uptick in domestic segment, biz growth continue to drive Ipca Laboratories",Further rerating of stock will hinge on USFDA resolution,positive,positive,1.815899581589962,positive,1.5709200169829198,positive
2020-02-12 18:01:13.485,665.38,720.5,650.8,711.38,1450942.0,Ipca Labs Q3 results: Profit up 24% to Rs 197 crore,"Total income also rose to Rs 1,230.99 crore for the quarter under consideration.",positive,positive,6.913342751510415,positive,0.4678770949720702,neutral
2020-02-12 18:02:25.799,665.38,720.5,650.8,711.38,1450942.0,"Ipca Labs at record close, up 6% on strong Q3 revenue growth",Domestic formulations segment registered a 15% growth YoY at Rs 485.6 crore and exports grew 25% to Rs 585.6 crore in Q3FY20.,positive,positive,6.913342751510415,positive,0.4678770949720702,neutral
2020-02-12 18:02:52.884,665.38,720.5,650.8,711.38,1450942.0,Ipca Labs Q3 net profit up 24% to Rs 197.54 cr,"Drug firm Ipca Laboratories on Wednesday reported a 24.15 per cent rise in consolidated net profit at Rs 197.54 crore for the quarter ended on December 31, 2019, on account of robust sales.The company",positive,positive,6.913342751510415,positive,0.4678770949720702,neutral
2020-02-14 18:02:36.461,716.0,754.15,702.5,719.35,1558584.0,"Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y","Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y",positive,positive,0.4678770949720702,neutral,-4.586518415566365,negative
2020-02-27 18:03:19.498,655.0,684.4,640.53,682.5,805066.0,"Positive on Hero MotoCorp, Ipca Labs: Abhimanyu Sofat","We are likely to see an impact on discretionary demand over the next couple of months if this coronavirus outbreak intensifies, says the head of research at IIFL Securities   ",neutral,neutral,4.198473282442748,positive,5.051244509516837,positive
2020-03-04 10:00:19.523,765.0,770.0,695.03,712.2,1098272.0,"Ipca Lab, Ajanta Pharma: Two pharma stocks HDFC Securities is bullish on","The level of 11,050 should be followed as a stop-loss on a closing basis in Nifty longs",positive,neutral,-6.90196078431372,negative,0.3846153846153846,neutral
2020-03-20 18:00:30.281,666.0,755.0,659.67,682.5,2717094.0,"Pharma stocks advance; Ipca Labs, Cadila Healthcare soar up to 19%","Given India is relatively better placed to scale up and due to lower outbreak of Covid-19, India may benefit by supplying more to US and EU, analysts say.",positive,positive,2.477477477477477,positive,-16.272503082614058,negative
2020-03-23 10:01:22.921,811.0,811.0,640.25,679.03,3269398.0,Ipca and Cadila Healthcare gear up to make drug for coronavirus,"Ipca is the biggest producer of the drug. Cadila Healthcare, based in Ahmedabad, too is a major player",positive,neutral,-16.272503082614058,negative,-7.959183673469387,negative
2020-03-23 13:01:54.337,735.0,737.5,627.62,676.5,1299030.0,Ipca Labs surges as USFDA partially lifts import ban for chloroquine supply,The medicine is considered one of the possible treatments for the Covid-19,positive,neutral,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-23 13:02:58.510,735.0,737.5,627.62,676.5,1299030.0,Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine,"The stock gained over 62 percent in the last 6 months and was trading with volumes of 19,120 shares",positive,positive,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-23 13:04:20.058,735.0,737.5,627.62,676.5,1299030.0,Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drug,"IPCA has a market share of nearly 70% of these drugs, as it is one of the largest suppliers of the active pharmaceutical ingredient of these medicines to several large multinational drug companies. Since the Covid-19 outbreak the company has supplied nearly 5 lakh tablets across the world. 
",neutral,neutral,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-23 18:03:43.894,735.0,737.5,627.62,676.5,1299030.0,IPCA Labs skids 5% after USFDA partially lifts import ban for Chloroquine supply,"USFDA has also informed that their exception will be re-considered if the shortage implications change, the company added.",neutral,neutral,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-23 23:01:22.662,735.0,737.5,627.62,676.5,1299030.0,Pharmaceutical company Ipca Laboratories share price reportedly rose over 12 per cent after the US Food and Drug Administration (USFDA) partially allowed import of chloroquine,Pharmaceutical company Ipca Laboratories share price reportedly rose over 12 per cent after the US Food and Drug Administration (USFDA) partially allowed import of chloroquine,positive,positive,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-23 23:02:20.864,735.0,737.5,627.62,676.5,1299030.0,"Covid-19 throws up drug supply opportunity for Ipca, other pharma firms","Sun Pharma, Dr Reddy's, Torrent Pharma, Cipla, Cadila Healthcare and Natco Pharma would also benefit from malaria drug supplies, Alembic Pharma from azithromycin sales",neutral,positive,-7.959183673469387,negative,-2.7366863905325447,negative
2020-03-25 23:00:09.189,657.5,684.5,616.72,656.5,1630678.0,"Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines","Leading Indian companies such as IPCA, Zydus Cadila are manufacturing anti-rheumatoid arthritis drugs like hydroxychloroquine and anti-malaria medicine like chloroquine. Cipla and Aurobindo are making anti-HIV medicines",neutral,neutral,-0.1520912547528517,neutral,-7.755406413124534,negative
2020-03-31 18:04:17.579,690.0,728.08,683.5,692.5,1670920.0,"Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19",Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.,positive,neutral,0.3623188405797101,neutral,-2.1536110482227797,negative
2020-04-01 10:02:09.455,690.0,728.08,683.5,692.5,1670920.0,"Ipca Lab, Pidilite Industries: Two stocks HDFC Securities is bullish on",The primary trend of Ipca Lab's stock has been bullish with higher tops and higher bottoms on the weekly and monthly charts,positive,positive,0.3623188405797101,neutral,-2.1536110482227797,negative
2020-04-03 10:02:24.520,706.72,714.97,690.0,691.5,581602.0,Covid-19: Indian pharma companies want government to airlift APIs from China,"IPCA Labs, Zydus Takeda, Mangalam Drugs & Organics and Wallace Pharma are among the manufacturers of this drug that are staring at fluctuating freight rates, a jump in prices of bulk drugs from Chinese suppliers and an erratic supply chain with cancelled or reduced frequency of cargo flights.",neutral,neutral,-2.1536110482227797,negative,-3.243952747046696,negative
2020-04-07 13:03:11.429,804.75,912.5,790.0,807.5,5603740.0,"Pharma stocks rally; Nifty Pharma index surges 10%, Ipca Labs hits new high","Torrent Pharmaceuticals also rose 15 per cent to a fresh 52-week high of Rs 2,380",positive,positive,0.3417210313762038,neutral,-7.080046403712294,negative
2020-04-07 15:57:00.000,804.75,912.5,790.0,807.5,5603740.0,Prepared to supply 10 crore tablets of Hydroxychloroquine to Indian government: IPCA Labs,Foreign ministry today said that it will lift the export ban for India’s neighbouring countries and those who are largely impacted by Covid-19.,neutral,positive,0.3417210313762038,neutral,-7.080046403712294,negative
2020-04-08 10:00:30.336,804.75,912.5,790.0,807.5,5603740.0,How IPCA Labs is best suited to reap the hydroxychloroquine opportunity,IPCA being one of the largest producer globally of both the API and formulation of hydroxychloroquine has an edge,positive,positive,0.3417210313762038,neutral,-7.080046403712294,negative
2020-04-08 10:01:22.850,804.75,912.5,790.0,807.5,5603740.0,"Coronavirus impact: Ipca, Cadila Healthcare stocks gain on India's HCQ move","Apart from the US, Brazil and Sweden have requested for the drug to battle the Covid-19 scare in their countries.",positive,neutral,0.3417210313762038,neutral,-7.080046403712294,negative
2020-04-08 14:47:55.000,862.0,862.0,775.0,800.97,3721858.0,"Pharma shares jump, Cadila Healthcare, IPCA Labs reach new highs on hopes of surging drug sales","After leading the rally on Dalal Street yesterday, pharmaceutical stocks are back, leading from the front yet again.",positive,positive,-7.080046403712294,negative,-4.507424065060678,negative
2020-04-08 18:02:04.450,862.0,862.0,775.0,800.97,3721858.0,Would avoid Ipca and Cadila at this juncture: Rahul Shah,"Defensives participate in a better way in bear market, says the VP for Broking at Motilal Oswal. ",neutral,positive,-7.080046403712294,negative,-4.507424065060678,negative
2020-04-09 13:01:33.316,862.0,862.0,775.0,800.97,3721858.0,"Ipca Laboratories, Zydus Cadila and Wallace Pharmaceuticals are major pharma firms manufacturing Hydroxychloroquine in India","Ipca Laboratories, Zydus Cadila and Wallace Pharmaceuticals are major pharma firms manufacturing Hydroxychloroquine in India",neutral,neutral,-7.080046403712294,negative,-4.507424065060678,negative
2020-04-13 07:38:00.000,811.55,812.0,772.5,774.97,1785230.0,Hydroxychloroquine production scaled up: Zydus Cadila,India manufactures 70% of the world’s supply of hydroxychloroquine — Zydus and Ipca Labs being the two biggest players.,neutral,neutral,-4.507424065060678,negative,-2.2239382239382204,negative
2020-04-13 19:31:27.000,811.55,812.0,772.5,774.97,1785230.0,Teva ships India’s first consignment of hydroxychloroquine to the US,"Ipca, Zydus also ready, but focus is on creating domestic buffer",neutral,neutral,-4.507424065060678,negative,-2.2239382239382204,negative
2020-04-15 15:55:33.000,751.62,779.95,751.62,759.97,1389802.0,IPCA Labs Says It Will Start Exporting Hydroxychloroquine To U.S. Soon,Ipca Laboratories says it will increase capacity to 13 crore tablets by June.,neutral,positive,1.110933716505684,positive,-3.161290322580645,negative
2020-04-16 08:28:00.000,751.62,779.95,751.62,759.97,1389802.0,"Stocks in news: TCS, Wipro, IPCA Labs, JSW Energy and more","Stocks to watch today on April 16: TCS, Wipro, IPCA Labs, JSW Energy, Bajaj Auto, Care Ratings, Man Industries India among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,1.110933716505684,positive,-3.161290322580645,negative
2020-04-22 07:58:00.000,799.0,799.4,775.0,779.0,1085574.0,"Nifty view and stock call by HDFC Securities: Buy Ipca Labs, Bharti Airtel",Bharti Airtels move remained resilient during the downtrend which the market witnessed in the current calendar year,neutral,positive,-2.503128911138924,negative,-1.8182978180426184,negative
2020-04-23 23:00:00.000,766.5,814.95,760.0,808.0,2241184.0,"Setback for Zydus, IPCA; US, Europe warn against using Hydroxychloroquine to treat coronavirus","European Medicines Agency said recent studies have reported serious, in some cases fatal, heart rhythm problems with chloroquine or hydroxychloroquine, particularly when taken in high doses or in combination with the antibiotic azithromycin",neutral,negative,5.414220482713633,positive,6.799230275817831,positive
2020-04-24 12:43:00.000,766.5,814.95,760.0,808.0,2241184.0,"Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs","Strides Pharma Science, Alkem Laboratories, Ajanta Pharma, Lupin, Ipca Laboratories, Jubilant Life Sciences and FDC were up in the range of 5 per cent to 10 per cent on the BSE",positive,positive,5.414220482713633,positive,6.799230275817831,positive
2020-04-30 08:27:00.000,800.0,814.6,782.8,810.0,1715948.0,"Stocks in the news: Reliance Industries, HUL, TechM, IPCA Labs and Motherson Sumi",Here are a few stocks which may buzz the most in Thursday’s trade.,neutral,neutral,1.25,positive,2.151898734177215,positive
2020-04-30 08:27:00.000,800.0,814.6,782.8,810.0,1715948.0,IPCA asks USFDA to clarify on Hydroxychloroquine risk,"Hydroxychloroquine, besides being administered as an anti-malarial drug, is also used as a chronic therapy by patients suffering from auto immune diseases such as RA and Lupus. In the recent months the drug has been used in several countries including India and US in the treatment of critically ill …",neutral,neutral,1.25,positive,2.151898734177215,positive
2020-04-30 11:01:00.000,800.0,814.6,782.8,810.0,1715948.0,Trending stocks: Ipca Laboratories share price down 1%,Shares of traded 0.78 per cent down in trade at 10:58AM on Thursday .,negative,negative,1.25,positive,2.151898734177215,positive
2020-05-13 08:47:00.000,780.0,780.0,765.08,768.0,309386.0,"Stocks to watch: Maruti, Vedanta, Jubilant Food, Ipca Labs, Nestle, Mphasis",Heres a look at the top stocks that may remain in focus today,neutral,neutral,-1.5384615384615383,negative,5.2700835581288175,positive
2020-05-13 13:35:00.000,759.95,809.4,759.92,800.0,980238.0,"MSCI India index rejig: Jubilant Food, Ipca Labs among 6 stocks added; 5 scrips removed","The changes announced in the May 2020 Semi-Annual Index Review for the MSCI Equity Indexes including India Domestic Index will be effective from May 29, 2020.",neutral,neutral,5.2700835581288175,positive,-0.3123048094940662,neutral
2020-06-01 10:15:06.000,748.0,766.17,733.0,762.55,1135404.0,These Lucky 7 Midcaps Turned Largecaps In The Last One Year; Time To Buy?,"As many as 7 stocks are now trading with a market-cap of more than Rs 20,000 crore, including Abbott India, Adani Green, Ipca Lab and Tata Consumer",neutral,neutral,1.9451871657753952,positive,1.7024620220010476,positive
2020-06-09 16:32:00.000,775.12,801.47,772.5,797.72,1112298.0,Ipca Lab will do very well irrespective of how market performs: IIFL,’Another stock that you could potentially look at is Laurus Lab,positive,neutral,2.9156775725049053,positive,-3.0380062305295943,negative
2020-06-16 05:30:00.000,799.5,812.0,755.55,796.0,1906120.0,BRIEF-India’s IPCA Laboratories March-Qtr Consol Net Profit Slips - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.4377736085053158,neutral,0.2574002574002574,neutral
2020-06-16 06:20:50.000,799.5,812.0,755.55,796.0,1906120.0,"Stocks To Watch: Axis Bank, HPCL, JK Tyre, IPCA Labs, Lakshmi Vilas Bank, NMDC, Shoppers Stop, Shriram Transport Finance, Tata Motors",Here are the stocks to watch in trade today.,neutral,neutral,-0.4377736085053158,neutral,0.2574002574002574,neutral
2020-06-16 08:31:00.000,799.5,812.0,755.55,796.0,1906120.0,"Board Meetings Today: HPCL, NMDC, IPCA Labs, Bank of Maharashtra and Kansai Nerolac",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,-0.4377736085053158,neutral,0.2574002574002574,neutral
2020-06-16 08:51:41.000,799.5,812.0,755.55,796.0,1906120.0,"Stocks in focus: RIL, IndiGo, Tata Motors, HPCL, Lakshmi Vilas Bank, among others to remain in news","HPCL, NMDC, Ashiana Housing, Bhansali Engineering Polymers, Bliss GVS Pharma, Globus Spirits, Ipca Laboratories, Bank of Maharashtra, and Schneider Electric Infrastructure are among 25 companies that are scheduled to announce their March quarter earnings today.",neutral,neutral,-0.4377736085053158,neutral,0.2574002574002574,neutral
2020-06-16 10:46:00.000,799.5,812.0,755.55,796.0,1906120.0,"US revokes decision to treat Covid-19 patients with hydroxychloroquine; jolt for Zydus Cadila, Ipca Lab","About six Indian companies like Cipla, Jubilant, Hetero, Syngene, Dr Reddy’s and Zydus Cadila were licensed to make and distribute the drug in over 120 geographies",neutral,neutral,-0.4377736085053158,neutral,0.2574002574002574,neutral
2020-06-16 15:34:00.000,777.0,789.5,770.0,779.0,918678.0,Ipca Labs Q4 results: Net profit declines 13.5% at Rs 83 crore,"Total income of the company stood at Rs 1,087.49 crore for the quarter under consideration.",negative,neutral,0.2574002574002574,neutral,3.161290322580645,positive
2020-06-16 16:55:35.000,777.0,789.5,770.0,779.0,918678.0,Ipca Lab’s net profit up by 43% at ₹652 crore for FY20,Ipca’s income from exports rose 24% to ₹2143.75 crore in FY20.For the March quarter the company recorded a net profit of ₹127.76 crore,positive,positive,0.2574002574002574,neutral,3.161290322580645,positive
2020-06-16 18:49:08.000,777.0,789.5,770.0,779.0,918678.0,Analysts See No Earnings Impact For Indian Suppliers As U.S. Bars Anti-Malarial Drugs For Covid-19,India is one of the largest suppliers of hydroxychloroquine to the U.S. Cadila Healthcare and Ipca Labs are the largest exporters.,neutral,neutral,0.2574002574002574,neutral,3.161290322580645,positive
2020-06-17 09:22:48.000,777.0,789.5,770.0,779.0,918678.0,"Ipca Labs Standalone March 2020 Net Sales At Rs 1,004.79 Crore, Up 20.51% Y-o-Y",,neutral,neutral,0.2574002574002574,neutral,3.161290322580645,positive
2020-06-18 17:54:01.000,800.5,812.5,792.5,810.03,664316.0,Buy IPCA Laboratories; Target Of Rs 1782: Emkay Global Financial,"Emkay Global Financial is bullish on IPCA Laboratories has recommended buy rating on the stock with a target price of Rs 1782 in its research report dated June 17, 2020.",neutral,positive,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-18 18:06:40.000,800.5,812.5,792.5,810.03,664316.0,Buy Ipca Laboratories; Target Of Rs 1900: ICICI Direct,"ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated June 17, 2020.",neutral,positive,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-18 18:14:23.000,800.5,812.5,792.5,810.03,664316.0,Accumulate IPCA Laboratories; Target Of Rs 1600: Dolat Capital,"Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 1600 in its research report dated June 17, 2020.",neutral,positive,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-18 18:20:23.000,800.5,812.5,792.5,810.03,664316.0,Buy Ipca Laboratories; Target Of Rs 1839: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1839 in its research report dated June 17, 2020.",neutral,positive,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-18 18:26:06.000,800.5,812.5,792.5,810.03,664316.0,Buy Ipca Laboratories; Target Of Rs 1750: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1750 in its research report dated June 17, 2020.",neutral,positive,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-19 07:56:00.000,800.5,812.5,792.5,810.03,664316.0,"Buy Ipca Labs, target price Rs 1,900: Anand Rathi",The brokerage believes a 12 per cent CAGR over FY20-22 in the domestic business is possible.,neutral,neutral,1.1905059337913768,positive,0.797057020232986,neutral
2020-06-24 05:30:00.000,835.0,835.0,812.58,827.5,845390.0,BRIEF-IPCA Laboratories Says US FDA Communicated Chloroquine Phosphate Drug Product Is No Longer In Shortage - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.8982035928143712,neutral,2.335586969883221,positive
2020-06-24 12:04:05.000,813.5,843.0,813.5,832.5,484372.0,USFDA Has Removed Partial Lifting Of Import Alert On APIs Manufacturing Facility At Ratlam: Ipca Laboratories,"In a regulatory filing Ipca Laboratories said, the US Food and Drug Administration (USFDA) has informed the company that the ""shortage implications for chloroquine phosphate API has changed and chloroquine phosphate drug product is no longer in shortage and therefore, no shipment of API chloroq…",neutral,neutral,2.335586969883221,positive,1.96383666626751,positive
2020-06-24 14:12:00.000,813.5,843.0,813.5,832.5,484372.0,USFDA has removed partial lifting of import alert on APIs manufacturing facility at Ratlam: Ipca Laboratories,"USFDA has also informed that due to potential shortage implications and/or medical necessity, exception to the import alert was made for API Hydroxychloroquine Sulfate",neutral,neutral,2.335586969883221,positive,1.96383666626751,positive
2020-06-24 17:35:00.000,813.5,843.0,813.5,832.5,484372.0,IPCA Lab says USFDA communicated Chloroquine Phosphate drug product is no longer in shortage; stock dips 1%,"USFDA has further informed that this exception will be re-considered if the shortage implications change, the company stated.",negative,neutral,2.335586969883221,positive,1.96383666626751,positive
2020-06-25 21:44:00.000,835.1,854.22,835.1,851.5,562650.0,How Trump’s hydroxychloroquine push became a boon for Ipca Laboratories,The US is still relying on Indian firms to import HCQ even after the drug fell out of favor as a Covid treatment.,negative,neutral,1.96383666626751,positive,-1.082821188176763,negative
2020-06-30 07:53:00.000,841.0,859.47,825.0,836.0,572466.0,"Buy Ipca Laboratories, target price Rs 1,774: Dharmesh Shah",The analyst suggested a stoploss at Rs 1625.,neutral,neutral,-0.5945303210463734,neutral,-1.1350059737156513,negative
2020-07-01 17:42:23.000,824.53,837.5,814.5,830.0,381768.0,"ICICI Direct expects HDFC Asset, L&T Info, 9 others in F&O soon","ICICI Direct expects 11 stocks — Aarti Industries, Abbott India, Adani Gas, Deepak Nitrate, HDFC Asset Management, ICICI General Insurance, IPCA Lab, L&amp;T Infotech, Pfizer, PI Industries and Tr",neutral,neutral,0.6634082446969822,neutral,-0.0565924142083115,neutral
2020-07-02 05:30:00.000,824.53,837.5,814.5,830.0,381768.0,BRIEF-IPCA Labs Says FDA Removed Exemption From Import Alert For Hydroxychloroquine Sulphate - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.6634082446969822,neutral,-0.0565924142083115,neutral
2020-07-02 09:06:41.000,824.53,837.5,814.5,830.0,381768.0,"Stocks in focus: Axis Bank, Abbott India, Pfizer, Hero MotoCorp, Dr Reddy’s Laboratories, India Cements","Aarti Industries, Ipca LabAdani Gas, ICICI General Insurance, PI Industries, and Trent, L&T Infotech, HDFC AMC, and Deepak Nitrite are among 11 stocks that are likely to be included in the futures & options (F&O) segment",neutral,neutral,0.6634082446969822,neutral,-0.0565924142083115,neutral
2020-07-02 16:40:00.000,830.5,844.5,825.0,830.03,260280.0,IPCA Lab update on USFDA exemption from import alert; stock dips ~1%,"The company said the USFDA through an e-mail on July 1, has informed that the shortage implications for Hydroxychloroquine Sulphate have changed.",positive,positive,-0.0565924142083115,neutral,0.7228915662650602,neutral
2020-07-06 09:54:17.000,830.0,855.0,827.5,836.0,451868.0,"IPCA Labs guidance should move investor focus beyond HCQS, accumulate","Recently, US FDA updated that HCQS has been removed from list of drug products in shortage. And hence, USFDA has taken away the exemption given for import alert to the company for HCQS. But there is much more to Ipca labs other HCQS opportunity which exudes confidence in FY21 guidance.",positive,neutral,0.7228915662650602,neutral,-1.6167664670658684,negative
2020-07-16 12:16:16.000,882.55,922.35,880.55,909.0,918146.0,Infosys Ltd leads gainers in ‘A’ group,"Mphasis Ltd, DCM Shriram Ltd, ICICI Securities Ltd and Ipca Laboratories Ltd are among the other gainers in the BSEs A group today, 16 July 2020.",positive,neutral,2.9969973372613503,positive,-0.5588702598802232,neutral
2020-07-31 11:35:00.000,874.95,951.0,874.95,940.05,1404224.0,Ipca Lab hits 52-week high in a range-bound market; stk surges 9% in 3 days,"According to Analysts at Phillip Capital, the companys revenues could grow 18 per cent year-on-year (YoY) to Rs 1,272.5 crore in June quarter of FY21",positive,positive,7.440425167152398,positive,-0.4739336492890995,neutral
2020-07-31 12:50:22.000,874.95,951.0,874.95,940.05,1404224.0,Essel Propack Ltd leads gainers in ‘A’ group,"Laurus Labs Ltd, Torrent Pharmaceuticals Ltd, Ipca Laboratories Ltd and Wockhardt Ltd are among the other gainers in the BSEs A group today, 31 July 2020.",positive,neutral,7.440425167152398,positive,-0.4739336492890995,neutral
2020-08-06 14:06:24.000,990.0,997.5,975.0,980.0,289538.0,"Massive landslide hits Sikkim’s Jorethang, IPCA lab damaged","A major landslide hit Sikkim’s Jorethang on Thursday. According to initial reports, the IPCA Laboratory in Mazhitar, Jorethang was badly damaged due to the landslide. A house was also completely washed away due to the landslide triggered by heavy rainfall in the area.",negative,negative,-1.0101010101010102,negative,5.892442740389464,positive
2020-08-10 14:03:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,Ipca Laboratories consolidated net profit rises 244.16% in the June 2020 quarter,Sales rise 42.31% to Rs 1534.40 crore,positive,positive,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-10 14:23:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,Ipca Lab spurts after Q1 PAT soars 244%,"Ipca Laboratories rallied 8.30% to Rs 2,118 after consolidated net profit surged 244% to Rs 445.68 crore on 42.31% jump in net sales to Rs 1,534.40 crore in Q1 June 2020 over Q1 June 2019.",neutral,positive,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-10 16:46:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,"Ipca Labs Consolidated June 2020 Net Sales at Rs 1,534.40 crore, up 42.31% Y-o-Y",,positive,neutral,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-10 17:04:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,"Ipca Labs Standalone June 2020 Net Sales at Rs 1,485.25 crore, up 46.91% Y-o-Y",,positive,neutral,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-10 19:35:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales,"The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing",positive,positive,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-11 08:08:00.000,1069.47,1078.47,992.5,1006.55,2706584.0,"Stocks in the news: ICICI Bank, Vodafone Idea, Titan, Motherson Sumi, IndiGo, IPCA Labs and BoB","The second largest private sector lender ICICI Bank set the floor price at Rs 351.36 per share for its proposed share sale to raise up to Rs 15,000 crore.",neutral,positive,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-11 10:46:10.000,1069.47,1078.47,992.5,1006.55,2706584.0,"IPCA’s Q1 show decent, but stock prices are riding on a wave of over-optimism","Its stock is up about 86% since January as demand for hydroxychloroquine jumped this year. But even while its latest results have impressed the Street, after a sharp run-up, the stock fell about 1.6% on Tuesday.",positive,positive,-5.883287983767668,negative,-0.1374501992031868,neutral
2020-08-11 13:27:24.000,1004.0,1015.5,972.5,1002.62,1059404.0,HCQ hype in pandemic leads to ₹259 crore additional sales for Ipca Lab in Q1,"During April-June, the drugmaker recorded strong growth in sales globally as leaders like US president Donald Trump and his Brazilian counterpart Jair Bolsonaro endorsed HCQ’s covid-19 treatment capacities",positive,positive,-0.1374501992031868,neutral,-1.3861386138613865,negative
2020-08-12 11:15:53.000,1004.0,1015.5,972.5,1002.62,1059404.0,"IPCA Labs: Healthy guidance, look beyond COVID opportunity","Overall, encouraged by a strong execution in Q1, IPCA labs has increased its revenue growth guidance for FY21 to 18-19 percent from 14-17 percent stated earlier.",neutral,positive,-0.1374501992031868,neutral,-1.3861386138613865,negative
2020-08-12 15:26:00.000,1010.0,1019.5,992.5,996.0,512634.0,Accumulate IPCA Laboratories ; target of Rs 2106: Dolat Capital,"Dolat Capital recommended accumulate rating on IPCA Laboratories with a target price of Rs 2106 in its research report dated August 12, 2020.",neutral,positive,-1.3861386138613865,negative,1.299548419468143,positive
2020-08-12 15:29:00.000,1010.0,1019.5,992.5,996.0,512634.0,Buy Ipca Laboratories; target of Rs 2400: ICICI Direct,"ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated August 11, 2020.",neutral,positive,-1.3861386138613865,negative,1.299548419468143,positive
2020-08-12 17:38:00.000,1010.0,1019.5,992.5,996.0,512634.0,Buy Ipca Laboratories; target of Rs 2365: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2365 in its research report dated August 11, 2020.",neutral,positive,-1.3861386138613865,negative,1.299548419468143,positive
2020-08-12 23:52:19.000,1010.0,1019.5,992.5,996.0,512634.0,"IPCA Lab rating: Retain ‘hold’ with revised target price of Rs 1,950","According to management, raw material cost pressures have waned and some part of cost savings are here to stay, which will drive margin.",positive,positive,-1.3861386138613865,negative,1.299548419468143,positive
2020-08-13 15:02:00.000,996.5,1014.65,995.08,1009.45,804354.0,Buy Ipca Laboratories; target of Rs 2420: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2420 in its research report dated August 11, 2020.",neutral,positive,1.299548419468143,positive,-1.0962962962962983,negative
2020-08-14 12:23:00.000,996.5,1014.65,995.08,1009.45,804354.0,Buy IPCA Labs; target of Rs 2300: Anand Rathi,"Anand Rathi is bullish on IPCA Labs has recommended buy rating on the stock with a target price of Rs 2300 in its research report dated August 12, 2020.",neutral,positive,1.299548419468143,positive,-1.0962962962962983,negative
2020-08-16 14:19:00.000,1012.5,1013.0,990.03,1001.4,417896.0,In process of obtaining environmental clearance for new plant in Madhya Pradesh: Ipca Labs,"Sharing information with the company’s shareholders, the drug maker said the company has already acquired land for the project.",neutral,neutral,-1.0962962962962983,negative,-0.189949578829072,neutral
2020-08-16 14:23:00.000,1012.5,1013.0,990.03,1001.4,417896.0,In process of obtaining environmental clearance for new plant in MP: Ipca,"Drug maker Ipca Laboratories is in the process of obtaining environmental clearance for a new manufacturing plant in Dewas, Madhya Pradesh, according to its 2019-20 annual report.",neutral,positive,-1.0962962962962983,negative,-0.189949578829072,neutral
2020-08-21 07:27:00.000,1015.03,1024.22,1000.03,1004.1,418248.0,"Pharma euphoria may reverse soon, and how!","Ipcas export formulations business grew by 89 per cent to 1,500 crore. Sales of HCQ for the quarter totalled Rs 200 crore. The share price of Ipca in the past six months has risen by 27 per cent to Rs 2,034 from Rs 1,599. Shares of the other two companies have also risen by about a fifth since the p…",neutral,positive,-1.0768154635823524,negative,0.5467102435709101,neutral
2020-09-02 12:41:00.000,1031.95,1031.95,1001.05,1004.0,250388.0,Board of Ipca Laboratories allots 5 lakh equity shares to promoters,At meeting held on 02 September 2020,neutral,neutral,-2.7084645573913506,negative,0.8558986936283052,neutral
2020-09-03 07:46:00.000,1031.95,1031.95,1001.05,1004.0,250388.0,"Stocks in the news | JSW Energy, Kalpataru Power Transmission, Rossari Biotech, Steel Exchange India, Coal India, Infibeam Avenues","Sterlite Technologies, Bhageria Industries, Dish TV India, Engineers India, Edelweiss Financial, Shilpa Medicare, Ipca Laboratories, JK Paper, Future Retail, Kirloskar Oil Engines, 3i Infotech are also among the stocks in focus today.",neutral,neutral,-2.7084645573913506,negative,0.8558986936283052,neutral
2020-09-08 18:29:54.000,990.5,1032.5,983.55,1020.5,750070.0,Going digital: Ipca Laboratories ties up with Dassault Systemes for ‘ONE Lab’ solutions,"In order to improve overall lab operations and digitalise its manufacturing QC labs, drug major Ipca Laboratories Ltd has partnered with Dassault Systemes for use of ‘ONE Lab’ industry solutions. Usin",neutral,positive,3.0287733467945483,positive,0.4878048780487805,neutral
2020-09-24 11:05:00.000,1062.5,1062.5,1023.83,1050.0,398048.0,"Emami, IPCA Labs: 5 defensive stocks you can buy in the current market","Despite the market correction, there are some stocks from the FMCG and pharma sectors - considered classic defensive plays - that can be bought from a medium-term perspective",neutral,neutral,-1.1764705882352942,negative,-0.9273050497285436,negative
2020-10-05 15:04:05.000,1079.25,1085.9,1058.68,1069.9,380684.0,Escorts Ltd leads losers in ‘A’ group,"Just Dial Ltd, Ipca Laboratories Ltd, Lakshmi Vilas Bank Ltd and Maharashtra Scooters Ltd are among the other losers in the BSEs A group today, 05 October 2020.",negative,negative,-0.8663423673847495,neutral,-0.9794776119402986,negative
2020-10-20 17:03:00.000,1036.0,1039.68,1026.5,1037.5,212274.0,These 12 companies see profit growth of more than 500% over last 5 fiscal years,"Privi Speciality Chemicals, Ipca Laboratories and Astrazeneca Pharma India are among the 12 names",positive,neutral,0.1447876447876447,neutral,4.854368932038835,positive
2020-10-27 10:46:00.000,1077.6,1220.72,1077.6,1195.0,4346886.0,"Ipca Labs rallies 9%, hits all-time high on hopes of healthy Q2 results","In Q2FY21, the companys Ebitda margins are likely to improve 740 basis points YoY to 28 per cent",positive,positive,10.894580549368978,positive,-1.5664690939881456,negative
2020-10-27 11:31:19.000,1077.6,1220.72,1077.6,1195.0,4346886.0,MSCI indices rejig: $2.5 billion to enter Indian market,"Kotak Bank, IPCA Lab, PI Ind to enter MSCI Global Index, says Morgan Stanley Research note",neutral,neutral,10.894580549368978,positive,-1.5664690939881456,negative
2020-10-27 11:32:03.000,1077.6,1220.72,1077.6,1195.0,4346886.0,IPCA Labs shares hit 52-week high on inclusion into MSCI indices,"The stock of IPCA Labs has hit a 52-week high on Tuesday on MSCI added the scrip to its rejigged indices.It had touched an intraday high of ₹2,319 (+8.97%) early in the day before settling down to tra",positive,positive,10.894580549368978,positive,-1.5664690939881456,negative
2020-10-27 12:01:00.000,1181.0,1230.0,1156.0,1162.5,1302580.0,Select stocks rally as MSCI to tweak foreign ownership limit in Indian stks,"Shriram Transport Finance, Asian Paints, Nestle India, L&T, Bajaj Finance, Colgate-Palmolive India, Shree Cement, Ipca Laboratories, NTPC and Pidilite Industries were up in the range of 3% to 8%",positive,positive,-1.5664690939881456,negative,2.1739130434782608,positive
2020-10-27 12:48:00.000,1181.0,1230.0,1156.0,1162.5,1302580.0,"Vedanta, Asian Paints, Colgate among 34 stocks look set to rally, suggests MACD","Stocks such as Vedanta, Asian Paints, Colgate Palmolive, IPCA Labs and Exide Industries are showing bullish signs.",positive,positive,-1.5664690939881456,negative,2.1739130434782608,positive
2020-10-27 18:39:00.000,1181.0,1230.0,1156.0,1162.5,1302580.0,IPCA Laboratories share hits all-time high on likely inclusion in MSCI India index,"IPCA Laboratories share hit all-time high today after global brokerage Morgan Stanley listed the pharma firm as a potential inclusion to the MSCI index. Share of IPCA Laboratories rose 14.67% to all-time high of Rs 2440.45 against previous close of Rs 2,",positive,positive,-1.5664690939881456,negative,2.1739130434782608,positive
2020-10-28 07:42:00.000,1181.0,1230.0,1156.0,1162.5,1302580.0,"Hot Stocks | Navin Fluorine, Shriram Transport, IPCA Laboratories can give 10-15% return in short term","Bank Nifty is looking much stronger than Nifty and we can expect it to test 25,000-25,250 levels in the coming sessions.",positive,positive,-1.5664690939881456,negative,2.1739130434782608,positive
2020-10-28 11:35:00.000,1181.0,1230.0,1156.0,1162.5,1302580.0,Buy these stocks for a 10% upside on MSCI’s new foreign ownership norms,Ipca Labs has tripled in the last one year from the lows of Rs 817 and continues to hold the same strength and momentum. Charts indicate more headroom from the current levels,positive,positive,-1.5664690939881456,negative,2.1739130434782608,positive
2020-11-09 13:32:00.000,1137.5,1142.5,981.05,1034.0,3500446.0,"Pharma shares underperform in a firm market; Glenmark, Ipca Labs fall 6%","In the past month, the S&P BSE Healthcare index underperformed the market by falling 5 per cent, as compared to 5.4 per cent rise in the S&P BSE Sensex",negative,negative,-9.0989010989011,negative,-4.245283018867925,negative
2020-11-09 15:04:19.000,1137.5,1142.5,981.05,1034.0,3500446.0,Lakshmi Vilas Bank Ltd leads losers in ‘A’ group,"Amber Enterprises India Ltd, Glenmark Pharmaceuticals Ltd, Ipca Laboratories Ltd and Heritage Foods Ltd are among the other losers in the BSEs A group today, 09 November 2020.",positive,negative,-9.0989010989011,negative,-4.245283018867925,negative
2020-11-09 17:05:42.000,1137.5,1142.5,981.05,1034.0,3500446.0,"ICICI Direct: Ipca Labs - Stable Topline, Strong Margin Performance In Q2","ICICI Direct: Ipca Labs - Stable Topline, Strong Margin Performance In Q2",neutral,neutral,-9.0989010989011,negative,-4.245283018867925,negative
2020-11-10 09:29:22.000,1137.5,1142.5,981.05,1034.0,3500446.0,IPCA Labs: Is vaccine anti-thesis to the pharma rally?,A key surprise is the IPCA’s confidence in sustenance of EBITDA margin of 25-26 percent in H2 FY21 on the back of both subdued raw material prices and cost-saving measures,positive,positive,-9.0989010989011,negative,-4.245283018867925,negative
2020-11-10 10:22:00.000,1137.5,1142.5,981.05,1034.0,3500446.0,"Buy Ipca Laboratories, target price Rs 2680: Motilal Oswal","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 28586.53 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-9.0989010989011,negative,-4.245283018867925,negative
2020-11-10 14:58:00.000,1060.0,1072.5,1003.5,1015.0,3399422.0,Stock market update: SmallCap stocks slip; Ipca Lab nosedives 10%,The S&P BSE SmallCap index was trading 0.44 per cent down at 15237.6.,negative,negative,-4.245283018867925,negative,2.294921875,positive
2020-11-10 15:04:38.000,1060.0,1072.5,1003.5,1015.0,3399422.0,Ipca Laboratories Ltd leads losers in ‘A’ group,"Thyrocare Technologies Ltd, Larsen & Toubro Infotech Ltd, Muthoot Finance Ltd and Dr Lal Pathlabs Ltd are among the other losers in the BSEs A group today, 10 November 2020.",neutral,negative,-4.245283018867925,negative,2.294921875,positive
2020-11-11 07:50:00.000,1060.0,1072.5,1003.5,1015.0,3399422.0,"Market Ahead, November 11: All you need to know before the opening bell","Media reports suggest ACC, Adani Green, Balkrishna Industries, Ipca Labs, and YES Bank have been included in the MSCI India index along with seven other stocks",neutral,neutral,-4.245283018867925,negative,2.294921875,positive
2020-11-11 11:26:00.000,1060.0,1072.5,1003.5,1015.0,3399422.0,Buy Ipca Laboratories: target of Rs 2560: Sharekhan,"Sharekhan is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2560 in its research report dated November 09, 2020.",neutral,positive,-4.245283018867925,negative,2.294921875,positive
2020-11-12 13:49:00.000,1049.95,1056.95,1027.5,1039.5,1031474.0,Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market,"Dolat Capital Market recommended accumulate rating on IPCA Laboratories with a target price of Rs 2369 in its research report dated November 09, 2020.",neutral,positive,-0.995285489785232,negative,0.0362778886268706,neutral
2020-11-12 16:02:00.000,1049.95,1056.95,1027.5,1039.5,1031474.0,Hold Ipca Laboratories; target of Rs 2393: Prabhudas Lilladher,"Prabhudas Lilladher recommended Hold rating on Ipca Laboratories with a target price of Rs 2393 in its research report dated November 10, 2020.",neutral,neutral,-0.995285489785232,negative,0.0362778886268706,neutral
2020-11-12 18:12:00.000,1049.95,1056.95,1027.5,1039.5,1031474.0,Buy Ipca Laboratories: target of Rs 2665: ICICI Direct,"ICICI Direct is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2665 in its research report dated November 09, 2020.",neutral,positive,-0.995285489785232,negative,0.0362778886268706,neutral
2020-11-13 15:09:00.000,1047.47,1050.0,1043.53,1047.85,64998.0,Buy Ipca Laboratories; target of Rs 2680: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2680 in its research report dated November 09, 2020.",neutral,positive,0.0362778886268706,neutral,0.5722460658082975,neutral
2020-11-23 10:52:00.000,1074.5,1140.0,1065.03,1093.88,2346652.0,"Pharma shares in focus; Divi’s Labs hits new high, Gland Pharma zooms 20%","Dishman Carbogen Amcis, Ipca Lab, SPARC, Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in the range of 4 per cent to 5 per cent on the BSE",neutral,positive,1.80362959516055,positive,-0.0180995475113163,neutral
2021-01-15 10:09:49.000,1074.47,1080.55,1046.0,1055.5,350324.0,Weekly Tactical Pick: IPCA Labs – Outperforms In Domestic Formulations Market,Ipca’s domestic secondary sales are about 12 percent for the quarter gone by. This is in line with management’s guidance for H2 FY21,neutral,positive,-1.7655216060011008,negative,1.2808349146110056,positive
2021-01-22 13:02:20.000,1027.5,1033.5,1006.4,1023.5,599752.0,Ipca Labs Q3 PAT Seen Up 4.9% YoY To Rs. 207.2 Cr: Yash Securities,"Net Sales are expected to increase by 3.8 percent Y-o-Y (down 7.5 percent Q-o-Q) to Rs. 1,259 crore, according to Yash Securities.",neutral,positive,-0.389294403892944,neutral,-2.896416298478154,negative
2021-02-04 09:16:00.000,1027.5,1027.75,980.55,995.0,1211906.0,Ipca Labs standalone profit 32% higher at Rs260cr; income rises 15%,Standalone EBITDA margin (before forex (gain)/loss) @ 26.98% in Q3 FY21 as against @ 24.46% in Q3 FY20,positive,neutral,-3.1630170316301705,negative,-3.3379790940766525,negative
2021-02-04 13:14:00.000,1004.5,1014.55,952.8,970.97,617228.0,IPCA Labs reports 35% YoY rise in Q3 PAT,"On a consolidated basis, IPCA Laboratories reported 35% jump in net profit to Rs 267.56 crore on a 16% rise in net total income to Rs 1425.21 crore in Q3 FY21 over Q3 FY20.",positive,positive,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-04 13:31:00.000,1004.5,1014.55,952.8,970.97,617228.0,Ipca Laboratories consolidated net profit rises 34.34% in the December 2020 quarter,Sales rise 16.24% to Rs 1409.83 crore,positive,positive,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-04 14:42:00.000,1004.5,1014.55,952.8,970.97,617228.0,Ipca Labs Q3 results: Net profit rises 35% to Rs 267.56 crore,"Its consolidated total income stood at Rs 1,425.21 crore for the quarter under consideration. It was Rs 1,230.99 crore for in the year-ago period, it added.",positive,neutral,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-04 17:44:55.000,1004.5,1014.55,952.8,970.97,617228.0,"Ipca Labs Consolidated December 2020 Net Sales At Rs 1,409.83 Crore, Up 16.24% Y-o-Y",,neutral,neutral,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-04 17:44:55.000,1004.5,1014.55,952.8,970.97,617228.0,"Ipca Labs Standalone December 2020 Net Sales At Rs 1,315.22 Crore, Up 15.46% Y-o-Y",,neutral,neutral,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-04 19:16:13.000,1004.5,1014.55,952.8,970.97,617228.0,Ipca Laboratories Q3 Net Profit Rises 35% To Rs 267.56 Crore,"The company had posted a net profit of Rs 197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing.",neutral,positive,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-05 17:42:43.000,1004.5,1014.55,952.8,970.97,617228.0,"Ipca Labs Q3 Review - Strong Export Tender, API Sales; Improved Margins: ICICI Direct","Ipca Labs Q3 Review - Strong Export Tender, API Sales; Improved Margins: ICICI Direct",neutral,neutral,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-05 17:56:00.000,1004.5,1014.55,952.8,970.97,617228.0,IPCA Laboratories Q3 PAT up 35.5% at Rs267.56cr on sales boost,"IPCA Laboratories reported 16.24% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs1,409.83cr",positive,positive,-3.3379790940766525,negative,0.8273009307135472,neutral
2021-02-08 10:32:15.000,967.0,999.5,966.05,975.0,465506.0,IPCA Labs: API Capacity Constraint Almost Out Of The Way,"IPCA continues to strive for vertical integration of its formulation production to the level of KSM (Key Starting Material). As of now, more than 60 percent of APIs used for formulations are produced in-house",neutral,neutral,0.8273009307135472,neutral,0.4122347193241339,neutral
2021-02-08 11:31:00.000,967.0,999.5,966.05,975.0,465506.0,"Buy Ipca Laboratories, target price Rs 2420: Motilal Oswal","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 25078.03 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.8273009307135472,neutral,0.4122347193241339,neutral
2021-02-10 16:28:28.000,981.92,989.0,967.5,971.5,302942.0,Buy Ipca Laboratories; Target Of Rs 2490: ICICI Direct,"ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2490 in its research report dated February 05, 2021.",neutral,positive,-1.0611862473521223,negative,-2.3405392076278124,negative
2021-02-16 10:09:00.000,945.0,954.4,938.97,950.5,468812.0,Ipca Labs on strong growth path: Why this pharma company is stock pick of the week,"Ipca with its vertical integration, cost advantage and strong export business has been able to manage good set of numbers. Having a strong balance sheet with low debt/equity ratio despite being in an investment phase is another positive for this counter which has made it a favourite of analysts.",positive,positive,0.582010582010582,neutral,-0.2232471936142883,neutral
2021-03-19 11:20:34.000,929.5,930.97,900.15,925.5,882392.0,Buy Ipca Laboratories: Target Of Rs 2560: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated March 18, 2021.",neutral,positive,-0.4303388918773533,neutral,-0.9735534160620112,negative
2021-04-12 08:38:07.000,1045.0,1107.5,1017.53,1075.0,1826294.0,Ipca Labs On A Steady Footing: Motilal Oswal,Ipca Labs On A Steady Footing: Motilal Oswal,neutral,neutral,2.8708133971291865,positive,-1.9360508224783364,negative
2021-04-12 10:26:00.000,1045.0,1107.5,1017.53,1075.0,1826294.0,"Buy Ipca Laboratories, target price Rs 2480: Motilal Oswal","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26968.76 Crore) operating in Pharmaceuticals sector.",neutral,neutral,2.8708133971291865,positive,-1.9360508224783364,negative
2021-04-12 12:04:19.000,1092.43,1104.43,1062.5,1071.28,824298.0,Solara Active Pharma Sciences Ltd leads gainers in ‘A’ group,"Suven Life Sciences Ltd, Cipla Ltd, Divis Laboratories Ltd and Ipca Laboratories Ltd are among the other gainers in the BSE’s ‘A’ group today, 12 April 2021.",positive,neutral,-1.9360508224783364,negative,-2.5494199535962903,negative
2021-04-12 13:18:06.000,1092.43,1104.43,1062.5,1071.28,824298.0,Buy Ipca Laboratories; Target Of Rs 2480: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2480 in its research report dated April 11, 2021.",neutral,positive,-1.9360508224783364,negative,-2.5494199535962903,negative
2021-04-12 19:18:47.000,1092.43,1104.43,1062.5,1071.28,824298.0,Broker’s call: Ipca Lab (Buy),"Motilal OswalTarget: ₹2,480CMP: ₹2,153.75From our interaction with the management, we believe Ipca Laboratories (IPCA) has enough levers to outperform the market in Domestic Formulations (DF) and Bran",neutral,positive,-1.9360508224783364,negative,-2.5494199535962903,negative
2021-04-12 20:13:20.000,1092.43,1104.43,1062.5,1071.28,824298.0,IPCA Q4 PAT Seen Up 126.5% YoY To Rs. 194.8 Cr: Sharekhan,"Net Sales are expected to increase by 21.1 percent Y-o-Y (down 7.8 percent Q-o-Q) to Rs. 1,300 crore, according to Sharekhan.",neutral,positive,-1.9360508224783364,negative,-2.5494199535962903,negative
2021-04-12 23:30:45.000,1092.43,1104.43,1062.5,1071.28,824298.0,"IPCA Labs: Reiterate ‘buy’, target price at Rs 2,480","Superior execution, market share gains to drive growth in DF. While doctors have resumed their clinics, partly on account of having received their vaccinations, patient footfall is yet to return to normal levels.",positive,positive,-1.9360508224783364,negative,-2.5494199535962903,negative
2021-04-14 05:30:00.000,1077.5,1096.97,1042.5,1050.03,424008.0,Why Brokerages are Positive on IPCA Labs,Why Brokerages are Positive on IPCA Labs,neutral,neutral,-2.5494199535962903,negative,0.942507068803016,positive
2021-04-15 08:45:09.000,1077.5,1096.97,1042.5,1050.03,424008.0,"Ipca Laboratories (₹2,159): Buy","The stock of Ipca laboratories recently broke out of a consolidation range and the psychological hurdle at ₹2,000 which brought back the bullish momentum. Therefore, the stock seems to have aligned w",neutral,positive,-2.5494199535962903,negative,0.942507068803016,positive
2021-04-16 07:50:06.000,1061.0,1081.88,1060.9,1071.0,588016.0,"Hot Stocks | IPCA Laboratories, HDFC Life, Marico Can Give Up To 33% Return In Short Term","On the upside, 14,616 will act as a make-or-break level. A break above it may see the NIfty move higher towards 15,000-15,050 and eventually towards 15,220.",neutral,positive,0.942507068803016,positive,1.4018691588785046,positive
2021-04-16 12:13:33.000,1061.0,1081.88,1060.9,1071.0,588016.0,"Firm domestic growth, export prospects keep street positive on Ipca Laboratories","Ipca Laboratories has remained a consistent performer over the last few quarters .Ipca Laboratories posted good traction in the pain/analgesics segment (up 39% year-on-year or y-o-y) and gastro (up 36% y-o-y) segment, according to analysts’ data",positive,positive,0.942507068803016,positive,1.4018691588785046,positive
2021-04-30 17:39:41.000,1037.5,1063.78,1033.32,1054.7,300890.0,"After Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma, now Ipca Laboratories invests Rs 25 crore in ABCD Technologies","Mumbai-based pharmaceuticals company Ipca Laboratories will complete the purchase of 4.03 per cent stake by April 30, 2021 in ABCD Technologies LLP (which will be renamed as IndoHealth Services LLP), stated the pharma company in its filing. The pharma company will be investing Rs 25 crore in ABCD…",neutral,neutral,1.6578313253012091,positive,0.4314285714285688,neutral
2021-05-21 09:43:00.000,1119.5,1126.15,1104.0,1115.0,715170.0,"Buy Ipca Laboratories, target price Rs 2335: Yes Securities","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 28015.29 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.401965163019205,neutral,0.1337494427106553,neutral
2021-05-28 08:20:56.000,1093.0,1143.0,998.05,1019.8,3319372.0,"Markets likely to gain on global cues; M&M, Sun Pharma, Glenmark in focus","Mahindra & Mahindra, REC, Ipca Laboratories, Sundaram Finance, Max Healthcare, Glenmark Pharmaceuticals, Aditya Birla Fashion & Retail, Indian Bank, City Union Bank and Dilip Buildcon are key companies which will announce their March quarter results today",positive,neutral,-6.697163769441908,negative,1.171303074670571,positive
2021-05-28 08:36:34.000,1093.0,1143.0,998.05,1019.8,3319372.0,"Infosys, Mahindra & Mahindra, Sun Pharma, Eicher Motors, IPCA Lab, UCO Bank stocks in focus","Nifty futures were trading 51.50 points or 0.33 per cent higher at 15,465.50 on Singaporean Exchange in early trade on Friday.",neutral,positive,-6.697163769441908,negative,1.171303074670571,positive
2021-05-28 14:47:00.000,1093.0,1143.0,998.05,1019.8,3319372.0,Ipca Laboratories consolidated net profit rises 87.58% in the March 2021 quarter,Sales rise 3.81% to Rs 1114.66 crore,positive,positive,-6.697163769441908,negative,1.171303074670571,positive
2021-05-28 16:07:00.000,1093.0,1143.0,998.05,1019.8,3319372.0,Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore,"Shares of Ipca Laboratories were trading at Rs 2,132.30 per scrip on BSE, down 3.06 per cent from the previous close.",positive,negative,-6.697163769441908,negative,1.171303074670571,positive
2021-05-31 19:22:34.000,1036.97,1058.25,1025.5,1034.5,397800.0,High base of Q4 led to a weak Q4 show for IPCA: FY22 guidance though encourages,The gains during 2020 were led by strong demand for its products as HCQS (Hydroxychloroquine) and many other ingredients that were used for Covid management,negative,positive,-0.2381939689672823,neutral,0.009616309260497,neutral
2021-06-01 10:30:00.000,1036.97,1058.25,1025.5,1034.5,397800.0,"Buy Ipca Laboratories, target price Rs 2400: Motilal Oswal","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26410.61 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.2381939689672823,neutral,0.009616309260497,neutral
2021-06-01 11:52:23.000,1036.97,1058.25,1025.5,1034.5,397800.0,Ipca Labs - Q4 An Aberration; Outlook Remains Intact: Motilal Oswal,Ipca Labs - Q4 An Aberration; Outlook Remains Intact: Motilal Oswal,neutral,neutral,-0.2381939689672823,neutral,0.009616309260497,neutral
2021-06-01 12:57:09.000,1039.9,1067.5,1033.5,1040.0,686570.0,Buy Ipca Laboratories: Target Of Rs 2560: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated May 31, 2021.",neutral,positive,0.009616309260497,neutral,-0.654659805603213,neutral
2021-06-01 12:58:42.000,1039.9,1067.5,1033.5,1040.0,686570.0,Buy Ipca Laboratories; Target Of Rs 2400: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2400 in its research report dated May 31, 2021.",neutral,positive,0.009616309260497,neutral,-0.654659805603213,neutral
2021-06-02 10:36:00.000,1039.9,1067.5,1033.5,1040.0,686570.0,IPCA Labs: Strong Margins To Sustain Even Post-COVID Opportunities,"In spite of the extraordinary sales of Hydroxychloroquine in FY21, IPCA Labs expects a 9-10 per cent growth in topline for FY22",neutral,positive,0.009616309260497,neutral,-0.654659805603213,neutral
2021-06-02 16:12:26.000,1049.4,1052.45,1033.5,1042.53,514102.0,Accumulate Ipca Laboratories Target Of Rs 2163: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 2163 in its research report dated June 01, 2021.",neutral,positive,-0.654659805603213,neutral,-1.715102429728442,negative
2021-06-10 07:52:05.000,1022.45,1032.47,1017.0,1020.0,426166.0,"Trade Spotlight | A Technical Indicator Signals Uptrend In Avanti Feeds, Ipca Laboratories: What Should Investors Do?",A Golden Cross is formed when a short-term moving average crosses above a long-term moving average. It signals an uptrend in the offing if the move is supported by an increase in volumes as well.,neutral,neutral,-0.2396205193408035,neutral,0.832517140058766,neutral
2021-06-11 09:06:00.000,1021.0,1031.25,1016.28,1029.5,843502.0,IPCA Lab makes Trophic Wellness a wholly-owned arm by acquiring a further 13.09% stake for Rs21.20cr,IPCA’s shareholding in TWPL has increased to 52.35%.,neutral,positive,0.832517140058766,neutral,2.099525095809724,positive
2021-06-11 17:04:00.000,1021.0,1031.25,1016.28,1029.5,843502.0,Ipca Labs acquires 13% stake in Trophic Wellness for Rs 21 crore,"The acquisition of the shares is for cash consideration of Rs 21.20 crore for 5,30,000 equity shares of TWPL, Ipca Labs added.",neutral,neutral,0.832517140058766,neutral,2.099525095809724,positive
2021-06-11 17:05:00.000,1021.0,1031.25,1016.28,1029.5,843502.0,Ipca Labs acquires 13.09% stake in Trophic Wellness for Rs 21.20 cr,"The company has acquired further 13.09 per cent of the equity share capital of Trophic Wellness Pvt Ltd. The company now holds 52.35 per cent of the paid-up equity share capital of Trophic Wellness Pvt Ltd (TWPL), Ipca Labs said in a regulatory filing.",neutral,neutral,0.832517140058766,neutral,2.099525095809724,positive
2021-07-02 08:19:00.000,1014.65,1016.97,1000.0,1004.5,222304.0,"3 stock ideas by Osho Krishan of Anand Rathi: Buy Havells, Ipca Labs",Motherson Sumi’s stock has seen some buying interest in the past trading sessions and settled well above all its major moving averages on the daily time frame,neutral,positive,-1.0003449465332852,negative,1.270534517842072,positive
2021-07-08 12:11:44.000,1050.0,1062.5,1040.5,1042.97,199538.0,"Pharma market growth declines sequentially in June, but nevertheless impresses","Wockhardt registered 48% year-on-year growth in June followed by Emcure Pharmaceuticals (up 27% YoY), Ajanta Pharma Ltd (up 24 % YoY), Abbott India Ltd (up 22% YoY), and Ipca Laboratories Ltd (up 22% YoY), said analysts at Motilal Oswal Financial Services",negative,positive,-0.669523809523807,neutral,0.954653937947494,positive
2021-07-08 21:20:00.000,1050.0,1062.5,1040.5,1042.97,199538.0,Don’t Miss IPCA Laboratories from Trading Perspective,Don’t Miss IPCA Laboratories from Trading Perspective,neutral,neutral,-0.669523809523807,neutral,0.954653937947494,positive
2021-07-12 19:56:44.000,1060.0,1060.35,1040.05,1044.0,102634.0,Ipca Lab Q1 PAT May Dip 53.5% YoY To Rs 207.6 Cr: ICICI Direct,"Net Sales are expected to decrease by 13.9 percent Y-o-Y (up 18.6 percent Q-o-Q) to Rs 1321.4 crore, according to ICICI Direct.",neutral,negative,-1.509433962264151,negative,3.358550571001774,positive
2021-07-16 07:40:00.000,1057.47,1057.5,1045.57,1048.5,109440.0,Ipca Laboratories to incorporate non-profit company ‘Ipca Foundation’; Stock gains,The main objective of incorporation is to carry out corporate social responsibility related and other charitable and support activities.,neutral,neutral,-0.8482510142131716,neutral,1.188825234082851,positive
2021-07-27 13:49:34.000,1114.5,1117.12,1075.0,1082.5,170224.0,"Markets slip as healthcare, banking stocks drag","Healthcare stocks including Sun Pharma lost 2.7%, APL Ltd 11%, SPARC 8%, Alembic Ltd 6%, Ipca Lab 4%, and Aurobindo Pharma 4%. .Banking stocks also fell with Axis Bank losing 3%, Kotak Mahindra Bank 2.2%, Bandhan Bank 1.1%, and Indusind Bank 0.6%.",neutral,negative,-2.871242709735307,negative,-1.509721762781643,negative
2021-08-05 10:01:00.000,1049.0,1122.07,1025.5,1050.0,1834776.0,Ipca Laboratories Q1FY22 consolidated Net Total Income at Rs1586.81cr; Stock ends 2% higher,Consolidated Net Profit down 31% in Q1FY22 at Rs306.67cr. EBIDTA margin at 27.36%.,positive,negative,0.0953288846520495,neutral,3.0947408391873843,positive
2021-08-05 14:18:00.000,1053.4,1090.0,1042.53,1086.0,558424.0,Ipca Laboratories consolidated net profit declines 31.26% in the June 2021 quarter,Sales rise 2.05% to Rs 1565.79 crore,negative,positive,3.0947408391873843,positive,5.0477489768076405,positive
2021-08-05 16:49:24.000,1053.4,1090.0,1042.53,1086.0,558424.0,Ipca Labs Q1 net profit declines 31% to Rs 306.67 cr; shares surge 2%,"Drug firm Ipca Laboratories on Thursday reported a 31.19 per cent decline in its consolidated net profit to Rs 306.67 crore for the quarter ended June 2021, mainly on account of rise in expenses.The company had posted a net profit of Rs 445.68 crore from the continuing operations for the c…",negative,negative,3.0947408391873843,positive,5.0477489768076405,positive
2021-08-05 18:54:00.000,1053.4,1090.0,1042.53,1086.0,558424.0,"Ipca Labs Consolidated June 2021 Net Sales At Rs 1,565.79 Crore, Up 2.05% Y-o-Y",,neutral,neutral,3.0947408391873843,positive,5.0477489768076405,positive
2021-08-09 11:48:45.000,1099.5,1161.5,1081.0,1155.0,1360758.0,IPCA Labs: Strong Revival For Domestic Formulations,"IPCA, which was mainly known a few years ago for anti-malarial medications, is now having a significant contribution from non-anti-malarial medicines",neutral,positive,5.0477489768076405,positive,3.766233766233766,positive
2021-08-09 12:13:04.000,1155.0,1210.0,1150.03,1198.5,1298784.0,Ipca Laboratories Share Price Rises 4%; CLSA Upgrades Rating,"The share touched a 52-week high of Rs 2,455.55 on October 28, 2020 and a 52-week low of Rs 1,786.05 on February 23, 2021",neutral,negative,3.766233766233766,positive,-0.0024999999999977,neutral
2021-08-09 17:30:00.000,1155.0,1210.0,1150.03,1198.5,1298784.0,"IPCA Labs share rises 5% despite weak Q1 earnings, here’s why","The pharma stock touched an intraday high of Rs 2,279.3 , rising 4.91% against previous close of Rs 2,172.65 on BSE",positive,positive,3.766233766233766,positive,-0.0024999999999977,neutral
2021-08-10 11:41:36.000,1155.0,1210.0,1150.03,1198.5,1298784.0,Buy Ipca Laboratories; Target Of Rs 2560: ICICI Direct,"ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated August 07, 2021.",neutral,positive,3.766233766233766,positive,-0.0024999999999977,neutral
2021-08-10 13:16:13.000,1200.0,1217.5,1177.5,1199.97,460016.0,IPCA Labs’ Shares Extend Gain As Brokerages Remain Optimistic After Q1 Results,Here’s what brokerages made of IPCA Labs’ Q1 FY22 performance...,neutral,neutral,-0.0024999999999977,neutral,-0.6225155628890745,neutral
2021-08-13 11:07:28.000,1197.5,1203.5,1182.5,1182.55,251260.0,Ipca’s malaria drug among three therapies being studied by WHO,It will be tested on hospitalised Covid-19 patients,neutral,neutral,-1.2484342379958284,negative,0.611858845587246,neutral
2021-08-24 15:04:03.000,1255.0,1272.5,1233.88,1241.5,266206.0,New India Assurance Company Ltd leads losers in ‘A’ group,"NELCO Ltd, Mahindra Logistics Ltd, KPIT Technologies Ltd and Ipca Laboratories Ltd are among the other losers in the BSE’s ‘A’ group today, 24 August 2021.",negative,negative,-1.0756972111553786,negative,2.174788562223117,positive
2021-08-27 09:47:19.000,1267.47,1292.5,1220.12,1225.0,512052.0,Nifty futures’ rollovers decline to 74%,"HAL, IEX, Ipca Lab, MCX among 10 stocks to enter F&O from today",negative,neutral,-3.3507696434629635,negative,0.8088773270465853,neutral
2021-08-27 14:33:00.000,1267.47,1292.5,1220.12,1225.0,512052.0,Select stocks gain on inclusion in F&O; Hindustan Aeronautics surges 9%,"Can Fin Homes, Polycab India, IndiaMART InterMESH, Oracle Financial Services, Syngene International, Dixon Technologies, MCX and Ipca Labs were up between 2 per cent and 3 per cent in intra-day trade.",positive,positive,-3.3507696434629635,negative,0.8088773270465853,neutral
2021-08-31 08:40:00.000,1245.0,1332.15,1215.5,1295.03,1793996.0,"L&T, Ipca Laboratories, TVS Motor in spotlight","L&T said that the company has completed the sale of its entire stake in L&T Uttaranchal Hydropower to ReNew Power Services consequent to completion of customary conditions precedent agreed under the Securities Purchase Agreement dated August 11,",neutral,neutral,4.018473895582328,positive,-2.74553571428572,negative
2021-08-31 12:52:00.000,1299.2,1321.22,1245.5,1263.53,546944.0,"Top stocks in focus: Larsen & Toubro, Axis Bank, Shriram EPC, Acrysil, Ipca Labs",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-2.74553571428572,negative,-2.009078350108549,negative
2021-08-31 15:40:00.000,1299.2,1321.22,1245.5,1263.53,546944.0,CRISIL reaffirms credit rating for Ipca Labs commercial paper; Stock under pressure,The credit rating agency has reaffirmed CRISIL A1+ rating on the company’s Rs50cr comer paper programme.,positive,positive,-2.74553571428572,negative,-2.009078350108549,negative
2021-08-31 17:45:00.000,1299.2,1321.22,1245.5,1263.53,546944.0,"Nifty Healthcare advances; Apollo Hospitals, Ipca Labs emerge top gainers","Fortis and Laurus Labs were also in the fast lane. On the flip side Biocon, Pfizer, and Alkem Lab were struggling.",positive,negative,-2.74553571428572,negative,-2.009078350108549,negative
2021-09-07 06:45:00.000,1257.5,1258.7,1224.03,1251.0,305282.0,CARE reaffirms credit ratings of Ipca Labs; Revises outlook to positive,The rating on the company’s long-term / short-term bank facilities Rs1140cr has been reaffirmed at CARE AA; Positive / Care A1+.,positive,positive,-0.5168986083499005,neutral,1.1103311849913728,positive
2021-09-07 11:44:32.000,1257.5,1258.7,1224.03,1251.0,305282.0,IPCA Labs leads top 10 Indian pharma companies in August,The 17.7% growth in the Indian pharma market during August was led by improving sales in the non-covid products portfolio even as traction in covid product sales continued,positive,positive,-0.5168986083499005,neutral,1.1103311849913728,positive
2021-09-13 14:48:36.000,1300.0,1339.9,1285.82,1335.6,456724.0,Buy Ipca Laboratories: Target Of Rs 2850: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2850 in its research report dated September 09, 2021.",neutral,positive,2.738461538461532,positive,-2.5974025974025974,negative
2021-09-30 06:30:00.000,1189.12,1218.47,1176.72,1212.43,379980.0,"Nifty Pharma stocks continue winning streak; Abbott India, IPCA Lab stocks outperform",Sun Pharma and Cadila also advanced to push the sectorial gains while Biocon and Lupin were also in the fast lane.,positive,positive,1.960273143164708,positive,-0.2812125222281844,neutral
2021-10-01 09:45:00.000,1209.05,1217.5,1195.0,1205.65,288760.0,Ipca Labs’ US arm acquires further 20% stake of Bayshore Pharmaceuticals,Bayshore is currently engaged in the selling & marketing of its own registered generics drug products as well as the registered generics drug products of other pharmaceutical companies.,neutral,neutral,-0.2812125222281844,neutral,-1.762295081967213,negative
2021-10-01 13:50:56.000,1209.05,1217.5,1195.0,1205.65,288760.0,"Ipca Laboratories acquires further 20% stake in Bayshore, New Jersey",For consideration of USD 1.2 mn,neutral,neutral,-0.2812125222281844,neutral,-1.762295081967213,negative
2021-10-06 18:00:47.000,1138.43,1192.5,1130.0,1178.93,682062.0,Ipca Laboratories Q2 PAT Seen Up 7.3% YoY To Rs 292.6 Cr: Prabhudas Lilladher,"Net Sales are expected to increase by 10.7 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs 1,437.2 crore, according to Prabhudas Lilladher.",neutral,positive,3.557530985655683,positive,-1.08921775898521,negative
2021-10-13 12:15:46.000,1181.95,1222.57,1181.95,1213.5,644280.0,"Dr Reddy’s, Ipca among outperformers in pharma market in September","Among therapies, respiratory, analgesics, gynaecology segments were outperformers, exhibiting a growth of 45.8%, 28.1%, 17.3% YoY respectively during the month",neutral,positive,2.6693176530310043,positive,-1.02880658436214,negative
2021-10-18 13:04:54.000,1207.57,1225.43,1159.5,1182.5,307712.0,"Ipca Laboratories Ltd soars 0.21%, rises for fifth straight session","Ipca Laboratories Ltd is quoting at Rs 2427.4, up 0.21% on the day as on 12:49 IST on the NSE. The stock is up 15.84% in last one year as compared to a 56.16% spurt in NIFTY and a 26.41% spurt in the Nifty Pharma.",positive,positive,-2.0760701242992075,negative,-1.480085653104923,negative
2021-10-18 13:50:41.000,1207.57,1225.43,1159.5,1182.5,307712.0,Ipca Laboratories Ltd continues to edge higher,"Ipca Laboratories Ltd is quoting at Rs 2427.4, up 0.21% on the day as on 12:49 IST on the NSE. The stock is up 15.84% in last one year as compared to a 56.16% spurt in NIFTY and a 26.41% spurt in the Nifty Pharma.",positive,positive,-2.0760701242992075,negative,-1.480085653104923,negative
2021-10-20 12:10:00.000,1181.5,1187.45,1082.25,1130.0,669540.0,IPCA Lab board to mull stock split on 13 Nov,The pharmaceutical company said its board will consider 2-for-1 stock split on 13 November 2021.,neutral,neutral,-4.358865848497673,negative,-0.8073827851644523,neutral
2021-10-20 12:18:01.000,1181.5,1187.45,1082.25,1130.0,669540.0,Ipca Labs board to consider stock split on November 13,"Ipca Labs board to meet on November 13 to consider stock split of every share held into 2 shares, the board will also consider declaration of interim dividend",neutral,neutral,-4.358865848497673,negative,-0.8073827851644523,neutral
2021-10-21 06:35:00.000,1181.5,1187.45,1082.25,1130.0,669540.0,"Nifty Pharma joins bear markets; Index sheds 1%; Strides, Granules soar while Gland Pharma, Laurus Labs emerge laggards","Dr Reddy’s also shed 2.65% while Glenmark and Lupin also were around 1.8% on the downside. IPCA Labs, Pfizer, and Cadila were also under heavy pressure.",neutral,neutral,-4.358865848497673,negative,-0.8073827851644523,neutral
2021-10-22 13:50:22.000,1143.2,1153.43,1115.62,1133.97,341878.0,Ipca Laboratories Ltd drops for fifth straight session,"Ipca Laboratories Ltd is quoting at Rs 2239.65, down 1.51% on the day as on 13:24 IST on the NSE. The stock jumped 2.95% in last one year as compared to a 51.73% rally in NIFTY and a 21.14% spurt in the Nifty Pharma index.",neutral,positive,-0.8073827851644523,neutral,-2.8010491872308,negative
2021-11-11 08:20:00.000,1107.5,1115.6,1095.0,1104.03,263614.0,"Nifty Pharma sheds 1.5% with majority stocks in free fall; Natco dives 6% ahead of Q2; Laurus Labs, Strides, Aurobindo, Sun Pharma drag too","Except for Torrent Pharma and IPCA Lab, all other stocks listed on the Nifty Pharma are trading in the red.",neutral,neutral,-0.3133182844243817,neutral,0.5092856432105693,neutral
2021-11-12 13:04:53.000,1105.47,1114.97,1060.05,1111.1,925156.0,"MSCI Adds Zomato, IRCTC, Mindtree, 4 Others To India Index; Ipca Labs, REC To Be Deleted","MSCI India Index Rejig | Under the smallcap segment, MSCI added total 69 companies in its Global Small Cap Indexes, however, deleted 10 companies. All changes will be implemented as of the close of November 30",neutral,neutral,0.5092856432105693,neutral,0.0454545454545454,neutral
2021-11-12 16:33:00.000,1105.47,1114.97,1060.05,1111.1,925156.0,"Key Results Today: Ashoka Buildcon, IPCA Labs, JK Cements, Godrej Industries in focus","These companies are from sectors such as cement, infrastructures and paints among others.",neutral,neutral,0.5092856432105693,neutral,0.0454545454545454,neutral
2021-11-17 05:30:00.000,1066.5,1074.9,1043.68,1049.45,1261640.0,"Brokerages Positive on IPCA Laboratories, Despite Tumbling Over 2%","Brokerages Positive on IPCA Laboratories, Despite Tumbling Over 2%",neutral,neutral,-1.5986872948898223,negative,0.6162734713529217,neutral
2021-11-17 08:44:01.000,1066.5,1074.9,1043.68,1049.45,1261640.0,"Ipca Labs - Soft Q2, Near-Term Growth Challenges: Dolat Capital","Ipca Labs - Soft Q2, Near-Term Growth Challenges: Dolat Capital",neutral,neutral,-1.5986872948898223,negative,0.6162734713529217,neutral
2021-11-17 11:06:28.000,1066.5,1074.9,1043.68,1049.45,1261640.0,"Brokerages See 16% Upside In Ipca Labs Despite Fall In Q2 Profit, Margin Headwinds",The drug firm reported a 6.30 percent fall in its consolidated net profit to Rs 250.23 crore for the second quarter ended September 30.,neutral,negative,-1.5986872948898223,negative,0.6162734713529217,neutral
2021-11-17 11:44:44.000,1066.5,1074.9,1043.68,1049.45,1261640.0,Ipca Labs Q2 Review - Temporary Margin Hiccup; Revenue Drivers Intact: Yes Securities,Ipca Labs Q2 Review - Temporary Margin Hiccup; Revenue Drivers Intact: Yes Securities,neutral,neutral,-1.5986872948898223,negative,0.6162734713529217,neutral
2021-11-17 13:01:33.000,1038.5,1049.5,1022.53,1044.9,1273138.0,Buy Ipca Laboratories; Target Of Rs 2450: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2450 in its research report dated November 17, 2021.",neutral,positive,0.6162734713529217,neutral,-2.702754289858939,negative
2021-11-17 16:42:00.000,1038.5,1049.5,1022.53,1044.9,1273138.0,Nifty Pharma under pressure; Healthcare stocks surge over 1%; Apollo Hospitals hits new high,"Metropolis Healthcare, Torrent Pharma, and Biocon were also in the fast lane. IPCA Labs, Lupin, Glenmark, Star, Auro Pharma, and Divis Lab were under pressure.",positive,neutral,0.6162734713529217,neutral,-2.702754289858939,negative
2021-11-17 19:08:39.000,1038.5,1049.5,1022.53,1044.9,1273138.0,Ipca Labs Q2 Review - Weak Quarter; Outlook Remains Positive: Prabhudas Lilladher,Ipca Labs Q2 Review - Weak Quarter; Outlook Remains Positive: Prabhudas Lilladher,neutral,neutral,0.6162734713529217,neutral,-2.702754289858939,negative
2021-11-18 10:38:17.000,1038.5,1049.5,1022.53,1044.9,1273138.0,IPCA Labs: Domestic Beat Offsets API Weakness,The key near-term challenge for IPCA is with respect to API sales. The company expects a softer Q3 due to the supply disruption in Sartan APIs and elevated raw material prices,neutral,positive,0.6162734713529217,neutral,-2.702754289858939,negative
2021-11-22 22:59:47.000,1017.62,1056.28,1002.47,1027.03,1842362.0,"Bulk Deals | Dolly Khanna Buys 1.4 Lakh Equity Shares In Ajanta Soya, Ipca Picks 3.65% Stake In Lyka Labs","Financial services group Societe Generale sold 4,62,468 equity shares in Fino Payments Bank at Rs 401.48 per share on the NSE. The stock corrected 12 percent to Rs 397.",neutral,neutral,0.924706668501009,positive,-0.9307692307692368,negative
2021-11-23 00:16:00.000,1017.62,1056.28,1002.47,1027.03,1842362.0,NSE-BSE bulk deals: Dolly Khanna buys stake in Ajanta Soya,"In another transaction, Ipca Laboratories bought 1.05 million shares of Lyka Labs at Rs. 123 per share through a bulk deal on the BSE.",neutral,neutral,0.924706668501009,positive,-0.9307692307692368,negative
2021-11-23 12:12:00.000,1040.0,1050.93,1008.03,1030.32,1214500.0,Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals,"On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals",neutral,neutral,-0.9307692307692368,negative,-2.4020117932709044,negative
2021-11-24 09:01:01.000,1040.0,1050.93,1008.03,1030.32,1214500.0,Stocks that will see action on November 24,"Buzzing stocks: Siemens, IPCA Lab, Lyka Labs, Bharti Airtel, Zee Entertainment, Patel Integrated, Poonawalla Fincorp, Affordable Robotic, HFCL",neutral,neutral,-0.9307692307692368,negative,-2.4020117932709044,negative
2021-11-24 09:06:00.000,1040.0,1050.93,1008.03,1030.32,1214500.0,Board of Ipca Laboratories approves acquisition of 26.57% in Lyka Labs,At meeting held on 24 November 2021,neutral,neutral,-0.9307692307692368,negative,-2.4020117932709044,negative
2021-11-24 12:47:43.000,1037.88,1070.22,1005.97,1012.95,2322648.0,IPCA Labs To Buy More Than 26% Stake In Lyka Labs; Shares Jump,"IPCA Laboratories has agreed to acquire more than 26% stake in Lyka Labs, triggering an open offer.",neutral,positive,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-24 12:49:00.000,1037.88,1070.22,1005.97,1012.95,2322648.0,IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer,IPCA Laboratories said that its board of directors has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs for a cash consideration of Rs 97.89 crore.,positive,neutral,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-24 14:58:00.000,1037.88,1070.22,1005.97,1012.95,2322648.0,Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs,"Lyka Labs is engaged in the manufacturing and marketing of injectables, lyophilized injectables and topical formulations",positive,neutral,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-24 19:07:54.000,1037.88,1070.22,1005.97,1012.95,2322648.0,Ipca to pick up 26.57 per cent stake in Lyka for ₹97.89 crore,Makes its entry into the lyophilized injectables business.,neutral,neutral,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-24 19:19:17.000,1037.88,1070.22,1005.97,1012.95,2322648.0,Ipca Laboratories to pick up 26.57% stake in Lyka for ₹97.89 cr,Makes its entry into lyophilized injectables biz,neutral,neutral,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-24 19:48:16.000,1037.88,1070.22,1005.97,1012.95,2322648.0,"Bulk Deals | Ipca Labs Picks 16.73% Stake In Lyka Labs, Dolly Khanna Buys 0.58% Shares In Simran Farms","In total, Ipca Labs, so far, bought 76,24,142 equity shares or 26.57 percent stake in Lyka Labs via open market transactions in the current week. Lyka Labs was locked in 5 percent upper circuit today at Rs 135.",neutral,neutral,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-25 10:41:22.000,1037.88,1070.22,1005.97,1012.95,2322648.0,Buy Ipca Laboratories: Target Of Rs 2675: Sharekhan,"Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2675 in its research report dated November 24, 2021.",neutral,positive,-2.4020117932709044,negative,-0.4663017921005342,neutral
2021-11-25 13:15:12.000,1012.22,1042.5,997.9,1007.5,2292076.0,Lyka Labs Acquisition By Ipca Laboratories Could Open Strong Growth Opportunities,Near-term growth potential seems to be moderate for Ipca Laboratories but the long-term growth levers are intact and the acquisition of Lyka Labs will likely open strong opportunities,neutral,positive,-0.4663017921005342,neutral,5.985037406483791,positive
2021-12-03 14:26:03.000,1027.5,1036.97,1014.67,1018.0,1524444.0,Buy Ipca Laboratories; Target Of Rs 2530: Edelweiss Securities,"Edelweiss Securities is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2530 in its research report dated December 02, 2021.",neutral,positive,-0.9245742092457422,negative,-0.9318293281020108,negative
2021-12-06 22:57:50.000,1009.0,1019.47,997.5,1000.5,1481592.0,Ipca Laboratories Rating ‘Buy’; Growth levers are intact for the company,"Normalcy likely to return in FY23 after a difficult FY22; ‘Buy’ maintained with a target price of Rs 2,530",neutral,positive,-0.8424182358771061,neutral,1.6417910447761193,positive
2021-12-09 12:14:58.000,1009.05,1042.6,1009.05,1027.5,1393694.0,"Ipca, AstraZeneca, Torrent, Sun Pharma outshine Indian pharma market in Nov","Growth in volume terms, however, remained flat year-on-year during November, but it was the 5.4% rise in prices and new product launches that helped drive IPM growth",neutral,positive,1.8284525048312812,positive,-0.8296730112249878,neutral
2021-12-10 12:49:37.000,1009.05,1042.6,1009.05,1027.5,1393694.0,"Mankind, IPCA, Torrent, Ajanta, Sun Lead Pharma Market Growth In November",The Indian pharmaceutical market grew over the preceding month in November amid recovering sales.,neutral,positive,1.8284525048312812,positive,-0.8296730112249878,neutral
2021-12-14 11:26:00.000,1015.0,1022.35,1007.0,1017.0,1003800.0,"Hold Ipca Laboratories, target price Rs 2240: Emkay Global","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 25653.30 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.1970443349753694,neutral,-0.7844290827082413,neutral
2021-12-24 23:16:35.000,1020.0,1024.57,1007.0,1010.17,214540.0,"GAIL, Ipca Labs, Zee Entertainment And More - Top Stock Picks For 2022: HDFC Securities","GAIL, Ipca Labs, Zee Entertainment And More - Top Stock Picks For 2022: HDFC Securities",neutral,neutral,-0.9637254901960826,negative,0.3974476562422924,neutral
2021-12-30 08:51:00.000,1061.0,1099.72,1050.97,1087.5,856346.0,Krebs Biochemicals & Industries board nods allotment of Rs100cr RNNCPS to IPCA Labs,The current market cap of the company is Rs348.42cr.,neutral,neutral,2.4976437323279925,positive,-0.5935779816513786,neutral
2022-01-02 15:49:51.000,1085.0,1093.38,1075.68,1078.2,271292.0,5 stocks to buy in 2022: Check HDFC Securities’ top picks,"Top stocks to buy in 2022: Aditya Birla Capital, GAIL, Hindustan Zinc, Ipca Labs and Mahindra and Mahindra.",positive,neutral,-0.6267281105990742,neutral,0.4101851851851911,neutral
2022-01-04 09:36:13.000,1080.0,1104.07,1080.0,1084.43,360200.0,Aarti Drugs To Ipca Labs: Analysts Expect Bulk Drug Makers To Overcome Margin Headwinds In 2022,What’s in store for API makers in 2022.,neutral,neutral,0.4101851851851911,neutral,0.0,neutral
2022-01-04 14:02:57.000,1092.5,1104.0,1060.62,1092.5,833636.0,"These 3 companies are likely to announce bonus, stock split. Details here","IPCA Laboratories, Hinduja Global Solutions and SBC Exports have informed Indian stock market exchanges that they are going to discuss stock bonus or stock split in their upcoming board meeting",neutral,neutral,0.0,neutral,-0.1162552779896207,neutral
2022-01-05 06:35:00.000,1092.5,1104.0,1060.62,1092.5,833636.0,"Nifty Pharma stocks trim early gains to trade flat; Alembic Pharma drags while Laurus Labs, Gland Pharma outperform","Cadila and Divis Lab were also under selling pressure. Granules India, Strides Pharma, and IPCA Labs were bullish.",negative,positive,0.0,neutral,-0.1162552779896207,neutral
2022-01-10 11:53:53.000,1123.95,1128.5,1028.4,1062.0,1498234.0,"Ipca, Ajanta, Sun, Torrent report strong sales growth during December: IPM data","The companies that derived large contributions from covid treatment drug sales during 2020 – Cadila Healthcare Ltd, Cipla Ltd , Glenmark Pharmaceuticals Ltd – saw a soft sales growth on a high base of last year",positive,positive,-5.511811023622052,negative,-0.3770028275212064,neutral
2022-01-10 14:30:00.000,1061.0,1076.95,1045.0,1057.0,311143.0,Ipca Labs down 6% as stock turns ex-date for 1:1 split,"The pharmaceutical company has fixed Tuesday, January 11, 2022, as the ‘record date’ for the members entitlement of sub-divided shares.",negative,neutral,-0.3770028275212064,neutral,-1.7428167687235046,negative
2022-01-10 15:05:18.000,1061.0,1076.95,1045.0,1057.0,311143.0,Garden Reach Shipbuilders & Engineers Ltd leads losers in ‘A’ group,"Ipca Laboratories Ltd, Coforge Ltd, JK Lakshmi Cement Ltd and AAVAS Financiers Ltd are among the other losers in the BSE’s ‘A’ group today, 10 January 2022.",positive,negative,-0.3770028275212064,neutral,-1.7428167687235046,negative
2022-01-10 17:49:09.000,1061.0,1076.95,1045.0,1057.0,311143.0,Ipca Laboratories - Two For One Share Stock Split: ICICI Direct,Ipca Laboratories - Two For One Share Stock Split: ICICI Direct,neutral,neutral,-0.3770028275212064,neutral,-1.7428167687235046,negative
2022-01-13 15:22:26.000,1061.7,1066.7,1045.05,1064.0,237545.0,Ipca Laboratories Q3 PAT May Dip 32.4% YoY To Rs 179.6 Cr: Prabhudas Lilladher,"Net Sales are expected to decrease by 2.2 percent Y-o-Y (down 10.8 percent Q-o-Q) to Rs 1,378.3 crore, according to Prabhudas Lilladher.",neutral,negative,0.2166337006687345,neutral,-0.2816901408450704,neutral
2022-01-17 07:02:00.000,1065.0,1078.8,1055.9,1062.0,249439.0,"MedPlus, Ipca, Honeywell among AMCs’ picks in December",Fund managers have shown a preference for bottom-up ideas in sectors beyond IT and pharmaceuticals in December when compared to the previous month. Two trends have clearly emerged in portfolio changes of leading fund houses in December 2021.,neutral,positive,-0.2816901408450704,neutral,-2.0514018691588825,negative
2022-01-17 13:16:55.000,1070.0,1072.4,1045.0,1048.05,314282.0,Ipca Laboratories Ltd rises around 1%,"Ipca Laboratories Ltd is quoting at Rs 1073.75, up 1.07% on the day as on 12:54 IST on the NSE. The stock is up 0.71% in last one year as compared to a 28.07% gain in NIFTY and a 9.93% gain in the Nifty Pharma index.",neutral,positive,-2.0514018691588825,negative,2.881844380403458,positive
2022-01-20 08:24:21.000,1073.0,1082.0,1061.6,1072.0,213815.0,Ipca Labs To Granules India: Bulk Drug Makers’ Q3 Margin Under Pressure,Raw material inflation to be a drag on API makers’ Q3 margins.,neutral,negative,-0.0931966449207828,neutral,0.1897533206831119,neutral
2022-01-20 10:57:00.000,1073.0,1082.0,1061.6,1072.0,213815.0,"Buy Ipca Laboratories, target price Rs 1300: Anand Rathi","Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 13572.54 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.0931966449207828,neutral,0.1897533206831119,neutral
2022-02-14 20:33:00.000,940.0,994.95,940.0,986.0,939902.0,Ipca Laboratories’ PAT declines 26% to Rs 199.9 crore in December quarter,"The company had posted a consolidated net profit of Rs 265.47 crore in the corresponding period last fiscal, Ipca Laboratories said in a regulatory filing",negative,neutral,4.893617021276596,positive,-1.3244363562834922,negative
2022-02-16 11:59:31.000,989.1,1002.05,971.2,976.0,371151.0,IPCA Labs: Does return of pre-COVID expenses derail investment case?,Ipca lab’s key challenge with respect to APIs is on the mend.,neutral,neutral,-1.3244363562834922,negative,-3.5464535464535465,negative
2022-02-16 17:30:00.000,1001.0,1001.0,955.15,965.5,1318463.0,Broker’s call: IPCA Lab (Buy),Motilal Oswal,neutral,neutral,-3.5464535464535465,negative,1.078278900984964,positive
2022-02-16 20:04:39.000,1001.0,1001.0,955.15,965.5,1318463.0,Buy Ipca Laboratories; target of Rs 1225: Prabhudas Lilladher,"Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1225 in its research report dated February 16, 2022.",neutral,positive,-3.5464535464535465,negative,1.078278900984964,positive
2022-02-16 20:05:06.000,1001.0,1001.0,955.15,965.5,1318463.0,Hold IPCA Laboratories; target of Rs 1060: Emkay Global Financial,"Emkay Global Financial recommended hold rating on IPCA Laboratories with a target price of Rs 1060 in its research report dated February 15, 2022.",neutral,positive,-3.5464535464535465,negative,1.078278900984964,positive
2022-02-17 11:19:14.000,1001.0,1001.0,955.15,965.5,1318463.0,Ipca Labs Shares Slip As Analysts Cut Targets After Q3 Miss,Here’s what brokerages made of Ipca Labs’ Q3 FY22 results...,neutral,neutral,-3.5464535464535465,negative,1.078278900984964,positive
2022-02-17 14:53:58.000,964.5,986.2,954.35,974.9,724877.0,Buy Ipca Laboratories; target of Rs 1190: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1190 in its research report dated February 15, 2022.",neutral,positive,1.078278900984964,positive,-0.411522633744856,neutral
2022-02-18 20:16:22.000,964.5,986.2,954.35,974.9,724877.0,"New PWM rules strengthen plastic collection, stresses on its reuse, recycling: IPCA | The Financial Express","Ashish Jain, the director of IPCA, an NGO providing waste management solutions, welcomed the government notification on extended producer responsibility (EPR) guidelines and said it promotes a circular economy and give clear direction to stakeholders.",positive,positive,1.078278900984964,positive,-0.411522633744856,neutral
2022-03-01 20:06:13.000,966.0,987.05,959.1,986.95,277324.0,Trade setup for Wednesday: Top 15 things to know before Opening Bell,"Based on the open interest future percentage, the top 10 stocks in which short-covering was seen included GSPL, ONGC, Apollo Hospitals, Crompton, GAIL and Ipca Labs",neutral,neutral,2.1687370600414124,positive,-1.4249492900608474,negative
2022-03-14 13:59:58.000,1017.5,1034.0,989.4,995.0,250777.0,Buy Ipca Labs; target of Rs 1200 : Motilal Oswal,"Motilal Oswal is bullish on Ipca Labs recommended buy rating on the stock with a target price of Rs 1200 in its research report dated March 11, 2022.",neutral,positive,-2.211302211302211,negative,0.1752804487179487,neutral
2022-03-31 15:51:59.000,1065.0,1065.0,1021.0,1028.0,355356.0,Rattanindia Power Ltd leads losers in ‘A’ group,"Hindalco Industries Ltd, Ingersoll-Rand (India) Ltd, Vardhman Textiles Ltd and Ipca Laboratories Ltd are among the other losers in the BSE’s ‘A’ group today, 31 March 2022.",negative,neutral,-3.4741784037558685,negative,0.257932645512932,neutral
2022-05-04 11:04:13.000,1011.65,1037.45,992.7,1000.0,307356.0,Volumes spurt at Ipca Laboratories Ltd counter,"Ipca Laboratories Ltd notched up volume of 1.92 lakh shares by 10:48 IST on BSE, a 40.74 fold spurt over two-week average daily volume of 4715 shares",neutral,positive,-1.1515840458656628,negative,-0.5171556439582342,neutral
2022-05-24 08:00:24.000,967.1,977.6,918.0,955.0,1587566.0,"Stocks to Watch: Maruti Suzuki, Zomato, Marico, ONGC","Companies that will announce their March quarter earnings today are Grasim Industries, Adani Ports, Balkrishna, Balrampur Chini, Bank of India, JM Financial, Ipca Labs, Minda Industries, Strides Pharma and Zee Media among others.",neutral,neutral,-1.2511632716368548,negative,-0.5291005291005291,neutral
2022-05-24 08:04:00.000,967.1,977.6,918.0,955.0,1587566.0,"Stocks to Watch: Zomato, Delhivery, SAIL, Ramco Cements, GAIL, BEL, Marico","Stocks to Watch: Grasim Industries, Adani Ports, JM Financials, Bank of India, Ipca Lab, Inox Wind, Jyothi Lab, and Metropolis Healthcare will be in focus ahead of their Q4 results today.",neutral,neutral,-1.2511632716368548,negative,-0.5291005291005291,neutral
2022-05-24 15:27:00.000,945.0,967.45,926.75,940.0,564337.0,IPCA Lab slips after Q4 PAT declines 19% YoY to Rs 130 cr,"IPCA Laboratories slumped 2.27% to Rs 954.90 after the company’s consolidated net profit fell 19.3% to Rs 130.23 crore despite of a 15.6% rise in net sales to Rs 1,289.10 crore in Q4 FY22 over Q4 FY21.",negative,negative,-0.5291005291005291,neutral,-1.9458364431176032,negative
2022-05-24 17:04:54.000,945.0,967.45,926.75,940.0,564337.0,"Ipca Labs Standalone March 2022 Net Sales at Rs 1,168.45 crore, up 12.25% Y-o-Y",,positive,neutral,-0.5291005291005291,neutral,-1.9458364431176032,negative
2022-05-24 18:29:00.000,945.0,967.45,926.75,940.0,564337.0,Ipca Labs Q4 net profit declines 19% at Rs 130 crore on higher expenses,"The company had posted a consolidated net profit after tax of Rs 161.34 crore in the same quarter previous fiscal, Ipca Laboratories said in a regulatory filing",negative,positive,-0.5291005291005291,neutral,-1.9458364431176032,negative
2022-05-26 13:28:46.000,920.0,923.55,898.7,900.3,733595.0,Ipca Labs Q4 Review - Domestic Formulation On Robust Growth Path: Motilal Oswal,Ipca Labs Q4 Review - Domestic Formulation On Robust Growth Path: Motilal Oswal,neutral,neutral,-2.141304347826092,negative,-0.2214839424141749,neutral
2022-05-27 14:04:49.000,920.0,923.55,898.7,900.3,733595.0,Ipca Laboratories Ltd slips for fifth straight session,"Ipca Laboratories Ltd is quoting at Rs 912.3, down 0.43% on the day as on 13:19 IST on the NSE. The stock tumbled 10% in last one year as compared to a 5.86% rally in NIFTY and a 9.3% fall in the Nifty Metal index.",neutral,negative,-2.141304347826092,negative,-0.2214839424141749,neutral
2022-05-30 11:17:14.000,903.0,909.0,884.3,901.0,673086.0,IPCA Labs: Growth outlook primed by domestic business,"Ipca is adding 1200 medical representatives with a focus on Ortho, Derma, and Cardiovascular therapies",neutral,neutral,-0.2214839424141749,neutral,-0.2652226765388416,neutral
2022-05-30 13:56:37.000,904.9,924.1,892.2,902.5,471913.0,Hold Ipca Laboratories : target of Rs 1080: Sharekhan,"Sharekhan recommended Hold rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated May 25, 2022.",neutral,neutral,-0.2652226765388416,neutral,-1.556441785753857,negative
2022-06-15 13:17:06.000,883.8,884.35,861.45,863.5,196691.0,Ipca Laboratories Ltd up for third consecutive session,"Ipca Laboratories Ltd is quoting at Rs 879.1, up 1.55% on the day as on 12:49 IST on the NSE. The stock is down 14.37% in last one year as compared to a 0.06% jump in NIFTY and a 13.64% jump in the Nifty Metal index.",positive,positive,-2.296899751074899,negative,0.651162790697677,neutral
2022-06-17 19:01:38.000,860.0,871.3,845.0,865.6,253253.0,Broker’s Call: Ipca Laboratories (Buy),Prabhudas Lilladher,neutral,neutral,0.651162790697677,neutral,1.146313364055305,positive
2022-06-23 17:14:28.000,901.8,905.0,886.75,887.4,146312.0,Buy Ipca Laboratories; target of Rs 1030: Motilal Oswal,"Motilal Oswal is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated June 22, 2022.",neutral,positive,-1.5968063872255462,negative,1.5939597315436242,positive
2022-06-29 22:56:25.000,894.0,907.8,887.35,890.15,433996.0,Trade setup for Thursday: Top 15 things to know before Opening Bell,"Based on the open interest future percentage, a long unwinding was seen in 91 stocks including Alembic Pharma, United Breweries, Honeywell Automation, Strides Pharma Science, and Ipca Laboratories",neutral,neutral,-0.4306487695749466,neutral,2.443133951137321,positive
2022-07-06 13:04:37.000,949.0,959.95,945.0,956.45,151653.0,"Ipca Laboratories Ltd spurts 1.67%, gains for five straight sessions","Ipca Laboratories Ltd is quoting at Rs 943.6, up 1.67% on the day as on 12:44 IST on the NSE. The stock is down 11.17% in last one year as compared to a 0.27% jump in NIFTY and a 15.04% jump in the Nifty Metal.",positive,positive,0.7850368809272966,neutral,2.2163258935539325,positive
2022-08-07 18:00:18.000,1019.0,1019.0,1002.45,1009.55,89240.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, a long unwinding was seen in 37 stocks including Bharat Electronics, Bosch, Firstsource Solutions, Ipca Laboratories, and Sun Pharma",neutral,positive,-0.9273797841020652,negative,-1.4875621890547308,negative
2022-08-12 15:31:10.000,988.4,990.0,918.4,927.5,3888843.0,Everest Kanto Cylinder Ltd leads losers in ‘A’ group,"Ipca Laboratories Ltd, Aster DM Healthcare Ltd, Divis Laboratories Ltd and Bharat Dynamics Ltd are among the other losers in the BSE’s ‘A’ group today, 12 August 2022.",negative,negative,-6.161473087818695,negative,-0.2208932708366957,neutral
2022-08-16 17:55:53.000,927.85,933.0,914.6,915.0,384538.0,Hold Ipca Laboratories: target of Rs 985: ICICI Direct,"ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 985 in its research report dated August 13, 2022.",neutral,positive,-1.384922131810101,negative,0.5761808990596243,neutral
2022-09-20 22:05:42.000,877.15,884.3,862.05,862.9,214193.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 100 stocks in which short-covering was seen including Hero MotoCorp, MCX India, IRCTC, Ipca Laboratories, and Hindalco Industries.",neutral,neutral,-1.6245796044006156,negative,1.5381057013993238,positive
2022-09-27 16:50:07.000,895.0,917.7,882.85,895.4,395792.0,Ipca Laboratories receives credit ratings from ICRA,Fund/ Non fund based working capital limits (Rs 1750 crore) - IND AA+/ Stable / IND A1+ (assigned),neutral,neutral,0.044692737430165,neutral,-0.0659630606860183,neutral
2022-09-29 05:59:00.000,909.6,912.75,896.15,909.0,269456.0,Investors seek safety in a stable pharma amid recession fears,"Stocks such as Divi’s Laboratories, Ipca, Dr Reddy’s, Cipla, and Alkem Laboratories have gained between 2% and 4% in the past week. The sector was in a consolidation phase in the past year due to a decline in business growth post-Covid, and valuations dropped about a fifth.",positive,positive,-0.0659630606860183,neutral,0.944386149003143,positive
2022-09-29 11:42:26.000,909.6,912.75,896.15,909.0,269456.0,Ipca Labs Management Meet Analysis - Profitability To Improve: Prabhudas Lilladher,The margins are likely to recover as revenues scale up with easing of certain overheads and raw material prices.,neutral,positive,-0.0659630606860183,neutral,0.944386149003143,positive
2022-09-29 17:50:32.000,905.35,917.45,896.0,913.9,193156.0,Accumulate Ipca Laboratories; target of Rs 1000: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1000 in its research report dated September 29, 2022.",neutral,positive,0.944386149003143,positive,1.9929019929019929,positive
2022-10-04 06:59:30.000,941.0,945.0,921.95,932.0,328709.0,Buy or sell: Vaishali Parekh recommends 2 stocks to buy today — Oct 4,Buy or sell stocks for today: Vaishali Parekh has recommended two stocks to buy today — IPCA Laboratories and Can Fin Homes,positive,positive,-0.9564293304994688,negative,-1.9911622211574225,negative
2022-11-11 18:04:46.000,892.8,903.2,835.3,865.7,782131.0,"Pharma stock trading at a discount of 23% from the high, 400% dividend declared","With a market valuation of ₹22,006.03 Cr., IPCA Laboratories Ltd. is a large-cap business that operates in the pharmaceutical industry.",neutral,neutral,-3.035394265232965,negative,0.0638051044083473,neutral
2022-11-15 08:47:32.000,867.95,876.9,862.65,869.95,262403.0,Ipca Labs Q2 Results Review - Negatives Priced In: Dolat Capital,"post sharp correction in stock we believe worst
case is captured in price with margin bottoming out.",neutral,negative,0.2304280200472377,neutral,0.7479861910241657,neutral
2022-11-17 18:34:23.000,867.0,870.15,851.3,866.7,203431.0,Broker’s Call: IPCA Laboratories (Accumulate),Prabhudas Lilladher,neutral,neutral,-0.0346020761245622,neutral,0.2427184466019312,neutral
2022-11-22 17:30:00.000,864.0,873.45,855.0,856.0,372597.0,"IPCA Labs, Concor among 9 stocks to go ex-dividend; Siemens results, Vedanta dividend & more","Manappuram Finance, IPCA Labs, EID Parry, GE Shipping, Container Corporation of India (Concor), ASM Technologies, Ingersoll-Rand, Pearl Global Industries and Morganite Crucible are going ex-dividend today",neutral,neutral,-0.9259259259259258,negative,-0.6819374016436466,neutral
2022-11-24 15:47:17.000,853.2,880.0,849.0,868.0,334147.0,Hold Ipca Laboratories; target of Rs 925: ICICI Direct,"ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 925 in its research report dated November 15, 2022.",neutral,positive,1.7346460384435012,positive,0.3491500200332057,neutral
2022-11-29 16:04:33.000,865.0,876.3,865.0,867.0,309006.0,Neutral Ipca Laboratories; target of Rs 908: Choice Equity Broking,"Choice Equity Broking recommended Neutral rating on Ipca Laboratories with a target price of Rs 908 in its research report dated November 15, 2022.",neutral,neutral,0.2312138728323699,neutral,-0.5747456750387953,neutral
2022-12-07 18:35:11.000,859.7,860.6,848.65,850.0,97314.0,Accumulate Ipca Laboratories; target of Rs 950: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 950 in its research report dated November 15, 2022.",neutral,positive,-1.1283005699662725,negative,0.2686915887850414,neutral
2022-12-20 08:58:45.000,858.6,874.7,848.3,872.5,305647.0,"Stocks that will see action on December 20, 2022","Buzzing stocks: LIC, IRCTC, Dabur, Wipro, Just Dial, NBCC (India), Securekloud Technologies, PTC India, Alembic Pharma, IPCA Lab, Balrampur Chini, Vishwaraj Sugar, Sterling and Wilson Renewable Energy",neutral,neutral,1.6189145119962702,positive,3.652968036529683,positive
2022-12-20 11:50:04.000,858.6,874.7,848.3,872.5,305647.0,Ipca Labs hikes stake in TWPL,Ipca laboratories announced that it added 6.53% stake in Trophic Wellness (TWPL) for total consideration of Rs 10.58 crore.,neutral,positive,1.6189145119962702,positive,3.652968036529683,positive
2022-12-20 17:30:00.000,865.05,904.35,865.05,896.65,874802.0,"Stocks in news: Just Dial, IRCTC, HDFC, Ipca Labs and more","Stocks to watch out for today: Just Dial, IRCTC, HDFC, PTC India, IRB Infrastructure Developers, NBCC India, Ipca Laboratories and more",neutral,neutral,3.652968036529683,positive,-3.0420353982300883,negative
2022-12-28 22:23:39.000,851.35,857.0,840.05,850.35,364571.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, 81 stocks have seen long unwinding on Wednesday, including Amara Raja Batteries, Ipca Laboratories, City Union Bank, Navin Fluorine International, and Balrampur Chini Mills.",neutral,negative,-0.1174605039055617,neutral,-1.7715617715617769,negative
2022-12-29 17:41:21.000,858.0,858.05,841.4,842.8,167876.0,Broker’s Call: Ipca Laboratories (Buy),Motilal Oswal Research,neutral,neutral,-1.7715617715617769,negative,-0.5945303210463734,neutral
2022-12-29 17:58:56.000,858.0,858.05,841.4,842.8,167876.0,Buy IPCA Laboratories; target of Rs 1000: Motilal Oswal,"Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1000 in its research report dated December 28, 2022.",neutral,positive,-1.7715617715617769,negative,-0.5945303210463734,neutral
2023-01-08 15:46:27.000,859.0,876.5,853.1,874.95,528732.0,Why do analysts see 40% potential upside for this pharma stock in 6 months?,"With a market valuation of ₹21,667.40 Cr, IPCA Laboratories is a large-cap company that engages in the pharmaceutical industry.",positive,neutral,1.85681024447032,positive,-0.684931506849315,neutral
2023-02-14 14:31:21.000,841.85,852.0,835.1,843.75,326577.0,Ipca Laboratories Q3 PAT drops 45% YoY to Rs 108 cr,The pharmaceutical company’s consolidated net profit tumbled 45.25% to Rs 107.84 crore in Q3 FY23 as compared to Rs 196.96 crore reported in Q3 FY22.,neutral,negative,0.2256934133159087,neutral,1.8990327907525384,positive
2023-02-14 17:30:00.000,841.85,852.0,835.1,843.75,326577.0,"Gateway Distriparks, MGL, Hikal to go ex-dividend; Adani Enterprises, Vodafone Idea, ONGC, JP Associates Q3 results today","PI Industries, GMR Airport Infrastructure, Torrent Power, Ipca Labs, Bata India, PNC Infra, CESC, Radico Khaitan and Indiabulls Housing would be some other companies that will disclose quarterly results later in the day.",neutral,neutral,0.2256934133159087,neutral,1.8990327907525384,positive
2023-02-17 11:07:49.000,854.0,854.0,815.0,831.0,1638083.0,"Ipca Labs slips 5%, hits 52-week low on weak December quarter results","In Q3, Ipca’s operating profit margin was lowest since FY19, impacted by lower gross margins, and continued higher overheads.",negative,negative,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 11:53:41.000,854.0,854.0,815.0,831.0,1638083.0,Ipca Laboratories sinks to 52-week low after Q3 profit dips,"Macquarie has an underperform rating on the stock, with the target at Rs 810 a share",negative,negative,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 15:16:04.000,854.0,854.0,815.0,831.0,1638083.0,Ipca Lab tumbles after broker issues underperform rating,Ipca Laboratories fell 3.87% to Rs 830.15 after a foreign broker reportedly issued underperform rating on the stock with a target price of Rs 810 per share.,negative,negative,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 16:01:15.000,854.0,854.0,815.0,831.0,1638083.0,Buy Ipca Laboratories; target of Rs 1100: YES Securities,"YES Securities is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 16, 2023.",neutral,positive,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 16:06:13.000,854.0,854.0,815.0,831.0,1638083.0,Accumulate Ipca Laboratories; target of Rs 865: Prabhudas Lilladher,"Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 865 in its research report dated February 17, 2023.",neutral,positive,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 16:15:52.000,854.0,854.0,815.0,831.0,1638083.0,Buy IPCA Laboratories; target of Rs 990: Motilal Oswal,"Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 990 in its research report dated February 16, 2023.",neutral,positive,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-17 17:30:00.000,854.0,854.0,815.0,831.0,1638083.0,"Ipca Laboratories shares hit 52-week low; should you buy, sell or hold?","Ipca Laboratories share price: Around 42,000 shares changed hands today on BSE, which was higher than the two-week average volume of 27,000 shares. Turnover on the counter stood at Rs 3.43 crore, commanding a market capitalisation (m-cap) of Rs 21,083.99 crore.",negative,positive,-2.693208430913349,negative,0.556934439130687,neutral
2023-02-20 06:58:48.000,825.95,844.0,819.0,830.55,323712.0,"Trade Spotlight | Your strategy for Shree Cement, Ipca Laboratories, IndusInd Bank today","Shree Cement climbed 2.5 percent to Rs 25,757, the highest closing level since May 2, 2022 and formed strong bullish candle on the daily charts with making higher high formation for fifth consecutive session. It traded with above average volumes.",neutral,positive,0.556934439130687,neutral,-2.2716346153846123,negative
2023-02-21 21:46:57.000,813.25,826.55,808.0,823.0,360305.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 71 stocks including LTIMindtree, Deepak Nitrite, Ipca Laboratories, Apollo Tyres and Persistent Systems witnessed a long unwinding.",neutral,neutral,1.1988933292345527,positive,-0.0182915675873394,neutral
2023-03-06 13:50:25.000,801.95,803.6,797.0,800.15,225137.0,Ipca Laboratories Ltd down for fifth straight session,"Ipca Laboratories Ltd is quoting at Rs 797.7, down 0.41% on the day as on 13:19 IST on the NSE. The stock tumbled 18.06% in last one year as compared to a 12% rally in NIFTY and a 5.69% fall in the Nifty Metal index.",negative,negative,-0.224452896065848,neutral,0.1999000499750153,neutral
2023-04-24 16:59:00.000,795.0,795.0,740.0,743.5,7900946.0,"Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore","“The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity shares of Rs 21- each, constituting about 33.38% of the paid-up equity share capital of Unichem Laboratories, a listed entity, from one of its promoter shareholders a…",neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 17:03:50.000,795.0,795.0,740.0,743.5,7900946.0,"IPCA Labs to buy 33.4% stake in Unichem Laboratories for Rs 1,034 crore","IPCA: The shares will be purchased at the cost of Rs 440 per share post the approval from the Competition Commission of India under the Competition Act, 2002",neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 17:30:00.000,795.0,795.0,740.0,743.5,7900946.0,"Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 cr at Rs 440 per share",Ipca is also making an open offer to the public equity·shareholders of Unichem to acquire from them up to 26% of the fully diluted outstanding equity share capital at a price of Rs 440 per share,neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 17:52:28.000,795.0,795.0,740.0,743.5,7900946.0,"IPCA Labs To Acquire 33.38% Stake In Unichem Laboratories For Rs 1,034 Crore",The company has entered into a definitive share purchase agreement for acquisition of 2.35 crore shares at Rs 440 per share.,neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 21:26:23.000,795.0,795.0,740.0,743.5,7900946.0,Ipca agrees to pick up 33% stake in Unichem,"lpca Laboratories has entered into an agreement to pick up 33.38 per cent equity in Unichem Laboratories for ₹1,034.06 crore, with an eye on exporting to developed markets.",neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 22:00:11.000,795.0,795.0,740.0,743.5,7900946.0,IPCA-Unichem deal: Here are the key takeaways,IPCA Labs has entered into a share purchase agreement with the promoter of Unichem Labs to acquire a 33.38 per cent stake. The current promoter of Uncihem will retain 12.8 per cent stake post the transaction.,neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-24 23:01:58.000,795.0,795.0,740.0,743.5,7900946.0,"Ipca Laboratories to acquire 33% stake in Unichem for 1,034 crore","The acquisition is subject to the fulfilment of terms and conditions as per the share purchase agreement, and statutory approvals from the Competition Commission of India, the company added",neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 01:21:00.000,795.0,795.0,740.0,743.5,7900946.0,"Ipca Labs set to acquire Unichem promoter’s stake for over ₹ 1,034 cr",The Mumbai-based Ipca will also make an open offer to the public equity shareholders of Unichem to acquire from them upto 26% of the fully diluted outstanding equity share capital at a price ₹ 440/- per share for ₹805.44 crore. The transactions are subject to approval of the Competition Commis-sion …,neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 07:30:43.000,795.0,795.0,740.0,743.5,7900946.0,"Buzzing Stocks: Infosys, HDFC Bank, Ipca Labs, Mahindra Logistics and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 08:59:58.000,795.0,795.0,740.0,743.5,7900946.0,Stocks that will see action today - April 25,"Buzzing stocks on April 25: Tata Consumer, Tata Steel Long Products, Bajaj Auto, HDFC Asset Management, AU Small Finance Bank, Dalmia Bharat, NAM-India, Infosys, Ipca Lab, Unichem, Crompton Greaves Consumer, Mahindra Lifespace, LTIMindtree, CAMS, Welspun",neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 09:07:12.000,795.0,795.0,740.0,743.5,7900946.0,Ipca Labs - Reviving U.S. Hopes Through Unichem Acquisition: Motilal Oswal,Ipca Labs has entered into a definitive share purchase agreement to acquire 23.5 million shares (a 33.3% stake) of Unichem.,neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 10:28:33.000,795.0,795.0,740.0,743.5,7900946.0,Ipca Labs at 52-week low on plans to acquire stake in Unichem Labs at premium,"Ipca Labs plans to acquire a 33.38 percent stake in Unichem Labs at Rs 400 per share, aggregating around Rs 1,034.06 crores.",negative,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 10:36:03.000,795.0,795.0,740.0,743.5,7900946.0,IPCA Laboratories Shares Slide To Nearly Three-Year Low After Unichem Deal,IPCA Labs has entered into a definitive share purchase agreement for the acquisition of 2.35 crore shares in Unichem Labs.,neutral,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 10:43:00.000,795.0,795.0,740.0,743.5,7900946.0,Ipca Labs shares tumble 9% on acquisition of stake in Unichem Laboratories,"Ipca Laboratories has agreed to buy 33.38% of the paid-up equity share capital of Unichem Laboratories for INR1,034.06 crore ($160m). The acquisition is subject to the approval of the Competition Commission of India. Ipca Laboratories board of directors also approved making an open offer to the publ…",negative,positive,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 11:09:29.000,795.0,795.0,740.0,743.5,7900946.0,"Ipca Labs dips 9%, hits 52-wk low on plan to buy 33.4% stake in Unichem Lab","Brokerages believe the acquisition is expensive, given increased competition in the US generics oral solids space, rising regulatory risks and strong efforts needed to turnaround Unichem Labs",neutral,neutral,-6.477987421383648,negative,-5.047297297297301,negative
2023-04-25 13:15:14.000,740.0,740.0,686.8,702.65,7375605.0,IPCA Labs stock hits valuation hurdle on Unichem stake acquisition,"IPCA Lab Shares: Unichem’s facilities are compliant with US regulations, but it posted losses for nine months of FY23",neutral,negative,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-25 17:30:00.000,740.0,740.0,686.8,702.65,7375605.0,"Ipca Laboratories shares hit 52-week low after Unichem deal, dive 10% to slip below Rs 750 mark","Ipca Labs share price: Premchand Godha, Promoter and Executive Chairman, lpca Labs said, “This acquisition is in line with our stated strategy to enhance our portfolio in our chosen growth markets. We both are well positioned to successfully integrate our product offerings and grow our businesses.”",negative,positive,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-25 17:30:00.000,740.0,740.0,686.8,702.65,7375605.0,"Sensex, Nifty edge lower in early trade; Crompton Greaves, Ipca Labs dive up to 10%","The 30-share BSE Sensex pack fell 33 points or 0.05 per cent to trade at 60,023, while the broader NSE Nifty moved 9 points or 0.05 per cent down to trade at 17,734. Mid- and small-cap shares were mixed as Nifty Midcap 100 shed 0.16 per cent and small-cap rose 0.18 per cent.",neutral,negative,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-25 17:30:00.000,740.0,740.0,686.8,702.65,7375605.0,"Sensex rises 75 points, Nifty settles above 17,750; RVNL rises 19%; IPCA Labs tanks 10%","BSE Sensex added 74.61 points, or 0.12 per cent, to close at 60,130.71, while NSE’s Nifty50 gained 25.85 points, or 0.15 per cent, to settle at 17,769.25 for the day.",positive,positive,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-25 17:30:00.000,740.0,740.0,686.8,702.65,7375605.0,"IPCA Labs shares: Unichem acquisition expensive, earnings dilutive in near term, says Motilal Oswal Securities","IPCA Labs: Motilal Oswal Securities said the acquisition is expensive, given increased competition in the US generics oral solids space, rising regulatory risks, strong efforts needed to turnaround Unichem,",neutral,negative,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-25 21:05:06.000,740.0,740.0,686.8,702.65,7375605.0,Better than most deals in recent years: Ipca on ‘expensive’ Unichem-buy,"A day after Ipca Laboratories agreed to pick up 33-odd per cent in Unichem Laboratories for about ₹1,034 crore, its stock price fell over 10 per cent, reflecting the analyst community’s concern with the deal.",neutral,negative,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-26 07:45:49.000,740.0,740.0,686.8,702.65,7375605.0,Ipca Labs Explains Unichem Deal Rationale As Shares Tumble,"Ipca Labs can benefit from cost efficiencies as Unichem has multiple spare capacities, its management said.",neutral,positive,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-26 11:15:48.000,740.0,740.0,686.8,702.65,7375605.0,Ipca Labs plunges 16% in two days; hits 3-year low on Unichem stake buy,"The acquisition will allow Ipca to re-enter US formulation generic market, however at 2.3x sales, as acquisition cost is expensive, given challenges and uncertainty associated with US market.",negative,positive,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-26 11:48:26.000,740.0,740.0,686.8,702.65,7375605.0,Hold Ipca Laboratories; target of Rs 750: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Ipca Laboratories with a target price of Rs 750 in its research report dated April 25, 2023.",neutral,positive,-5.047297297297301,negative,-0.2282453637660517,neutral
2023-04-26 13:32:10.000,701.0,706.25,690.2,699.4,2029600.0,Hold IPCA Laboratories; target of Rs 790: Sharekhan,"Sharekhan recommended Hold rating on IPCA Laboratories with a target price of Rs 790 in its research report dated April 25, 2023.",neutral,neutral,-0.2282453637660517,neutral,1.355206847360913,positive
2023-04-26 17:30:00.000,701.0,706.25,690.2,699.4,2029600.0,"Sensex rises 170 points, Nifty tops 17,800; Gujarat PSU stocks rally up to 20%; Ipca Labs tanks 5%","BSE Sensex rose 169.87 points, or 0.28 per cent, to settle at 60,300.58. NSE’s Nifty50 gained 44.35 points, or 0.25 per cent, to close at 17,813.60 for the day.",positive,positive,-0.2282453637660517,neutral,1.355206847360913,positive
2023-04-26 17:30:00.000,701.0,706.25,690.2,699.4,2029600.0,"Ipca Laboratories shares slip below Rs 700, hit fresh 52-week low; more downside possible?","Ipca Labs share price: Technical analysts largely felt that the stock looked ‘bearish’. One of them suggested that a closing below the support zone of Rs 718 may bring further weakness, while another said the stock could witness selling pressure in the near term.",negative,negative,-0.2282453637660517,neutral,1.355206847360913,positive
2023-04-26 17:30:00.000,701.0,706.25,690.2,699.4,2029600.0,"Sensex falls over 150 points, Nifty trades below 17,750; Ipca Labs, Brightcom Group tank up to 6%","The 30-share BSE Sensex pack fell 158 points or 0.26 per cent to trade at 59,972, while the broader NSE Nifty moved 46 points or 0.26 per cent down to trade at 17,722. Mid- and small-cap shares were mixed as Nifty Midcap 100 fell 0.45 per cent and small-cap edged 0.07 per cent higher.",neutral,negative,-0.2282453637660517,neutral,1.355206847360913,positive
2023-04-27 08:25:00.000,701.0,706.25,690.2,699.4,2029600.0,"Big Movers on D-St: What should investors do with KEI Industries, Ipca Laboratories and GSFC?","The Indian market closed higher on Wednesday, with S&P BSE Sensex up over 150 points and Nifty50 above 17800 levels. The buying was seen in realty, capital goods, telecom, and power sectors but selling was visible in metals, oil & gas, energy, and healthcare sectors. KEI Industries stock surged up t…",neutral,positive,-0.2282453637660517,neutral,1.355206847360913,positive
2023-04-27 15:15:54.000,701.0,713.35,697.0,710.5,1258749.0,Pharma firm Ipca Labs’ plant gets 3 observations from US drugs regulator,Ipca Labs vs US FDA: The observations were followed by the USFDA inspection at the site from April 18 to April 26,neutral,neutral,1.355206847360913,positive,-0.8333916940962315,neutral
2023-04-27 17:15:45.000,701.0,713.35,697.0,710.5,1258749.0,Neutral IPCA Laboratories; target of Rs 760: Motilal Oswal,"Motilal Oswal recommended Neutral rating on IPCA Laboratories with a target price of Rs 760 in its research report dated April 26, 2023.",neutral,neutral,1.355206847360913,positive,-0.8333916940962315,neutral
2023-05-15 08:07:01.000,696.05,700.95,688.65,694.6,455689.0,Ipca Labs - Long Road Ahead For U.S. FDA Compliance: Motilal Oswal,Multiple milestones to be crossed for revival of U.S. generics business.,neutral,positive,-0.2083183679333283,neutral,-1.1869011869011803,negative
2023-05-15 11:51:06.000,696.05,700.95,688.65,694.6,455689.0,Ipca Laboratories Faces U.S. FDA Scrutiny Over Three Lapses At Silvassa Facility — BQ Exclusive,U.S. FDA inspected the Silvassa facility from April 18 to April 26 and issued Form 483 with three observations.,neutral,neutral,-0.2083183679333283,neutral,-1.1869011869011803,negative
2023-05-16 16:23:00.000,690.0,691.85,681.0,684.7,448658.0,Neutral IPCA Laboratories; target of Rs 760: Motilal Oswal,"Motilal Oswal recommended Neutral rating on IPCA Laboratories with a target price of Rs 760 in its research report dated May 14, 2023.",neutral,neutral,-0.7681159420289789,neutral,-1.8829516539440272,negative
2023-05-17 17:30:00.000,687.75,687.75,670.6,674.8,545943.0,"Sensex dives over 500 points: Rs 1.4L cr investor wealth lost; LIC Housing, Oberoi Realty, PVR & Adani Total down up to 7%","As many as 26 stocks hit their 52-week lows today. BSE 500 stocks such as Aditya Birla Fashion and Retail, Ipca Labs, PVR Inox and VMart hit their respective one-year low levels. That said, 115 stocks touched their one-year high levels today.",negative,negative,-1.8829516539440272,negative,-0.7057785619761899,neutral
2023-05-22 14:23:30.000,683.0,690.95,679.8,690.0,482258.0,"Jet Airways, Mankind Pharma, IPCA Labs among 32 NSE stocks to hit 52-week lows; 68 touch 52-week highs | The Financial Express","The NSE Nifty 50 and BSE Sensex were trading higher today. In sectoral indices, Bank Nifty tanked 230 points or 0.52% to 43,739.1 while Nifty FMCG was up 0.32%, Nifty Pharma was up 0.76%, Nifty IT jumped 1.61% and Nifty Metal surged 2.57%.",positive,positive,1.0248901903367496,positive,-1.0144927536231882,negative
2023-05-24 06:57:11.000,690.0,690.0,682.0,683.0,267660.0,"Stocks To Watch: Wipro, Infosys, Adani Green, Ashok Leyland, Biocon, Bajaj Electricals, NMDC, IPCA Labs | The Financial Express",Buzzing stocks: The SGX Nifty hinted at a start in the red for domestic indices NSE Nifty and BSE Sensex. Here’s a look at the stocks to watch in trade today.,neutral,neutral,-1.0144927536231882,negative,-0.4964953271028004,neutral
2023-05-29 05:00:00.000,686.45,691.35,675.45,687.95,961188.0,"Torrent Power, Adani Transmission, Ipca Labs, NHPC Q4 Results Today: Here’s What To Expect",Here are the estimates of earnings by major companies scheduled to be announced today.,neutral,neutral,0.2185155510233811,neutral,-0.3840579710144894,neutral
2023-05-29 06:39:42.000,686.45,691.35,675.45,687.95,961188.0,"Stocks To Watch: Torrent Power, Allcargo Logistics, Adani Transmission, Ipca, ONGC, BHEL, RIL, HDFC, IRCTC",Stocks to watch before going into trade today.,neutral,neutral,0.2185155510233811,neutral,-0.3840579710144894,neutral
2023-05-29 15:55:25.000,690.0,693.9,683.05,687.35,680119.0,IPCA Laboratories Q4 results: Net profit declines 41% to Rs 76.52 crore,"The company’s consolidated revenue from operation rose by 17.3 per cent to Rs 1,512 crore for the March quarter",negative,positive,-0.3840579710144894,neutral,1.5942028985507246,positive
2023-05-30 07:44:42.000,690.0,693.9,683.05,687.35,680119.0,"Top Stocks to watch: Adani Transmission, ONGC, IRCTC, IPCA Labs, Torrent Power","Business Standard | Stocks to watch today | May 30, 2023: From ONGC to Adani Transmission, here are top stocks to watch in Tuesday’s trading session",neutral,neutral,-0.3840579710144894,neutral,1.5942028985507246,positive
2023-06-05 09:40:39.000,704.65,726.6,700.15,724.3,737236.0,"Stocks to watch today — June 5, 2023","Railway stocks, NTPC, IOC, Tech Mahindra, Induce Remedies, Vedanta, Lemon Tree Hotels, Lupin, Bajaj Finserv, IPCA Lab, Wonderla Holidays and Indo Rama Synthetics",neutral,neutral,2.788618463066768,positive,2.3013698630136923,positive
2023-06-05 14:39:13.000,730.0,753.0,719.55,746.8,1507999.0,Ipca says IT Dept surveyed offices and manufacturing plants,"Joins string of drug companies under ITD lens, including Mankind last month",neutral,neutral,2.3013698630136923,positive,-0.3542780748663071,neutral
2023-06-05 18:09:04.000,730.0,753.0,719.55,746.8,1507999.0,Drugmaker Ipca says Income Tax Dept surveyed offices and manufacturing plants,"Joins string of drug companies under ITD lens, including Mankind last month",neutral,neutral,2.3013698630136923,positive,-0.3542780748663071,neutral
2023-06-12 22:23:06.000,731.55,748.2,729.25,734.05,1310671.0,Trade setup for Tuesday: Top 15 things to know before the opening bell,"Based on the OI percentage, 80 stocks, including Manappuram Finance, Hindustan Petroleum Corporation, Ipca Laboratories, Delta Corp and BPCL, saw a long build-up.",neutral,neutral,0.341740140796938,neutral,-2.5815217391304346,negative
2023-06-14 09:55:13.000,736.0,740.5,712.4,717.0,1768579.0,Ipca Laboratories down 3% after USFDA flags concerns about MP unit,"Earlier this month, the company said the income tax department carried out “survey proceedings” at its offices in Mumbai and at manufacturing plants in Sikkim",negative,neutral,-2.5815217391304346,negative,0.964900013984055,positive
2023-06-14 14:32:33.000,715.1,727.5,710.0,722.0,420304.0,USFDA issues 11 observations following inspection of Ipca Labs facility in Ratlam,"The Income Tax Department conducted survey proceedings at Ipca Labs Mumbai offices and manufacturing plants in Sikkim between May 30-June 3, 2023.",neutral,neutral,0.964900013984055,positive,1.876731301939052,positive
2023-06-14 15:08:29.000,715.1,727.5,710.0,722.0,420304.0,Ipca Labs API plant in Ratlam gets 11 U.S. FDA observations,"Drugmaker Ipca Laboratories’ active pharmaceutical ingredients (API) manufacturing facility in Ratlam, Madhya Pradesh, has been issued Form 483 with 11 observations by the U.S. Food and Drug Administration (U.S. FDA).",neutral,neutral,0.964900013984055,positive,1.876731301939052,positive
2023-06-14 17:30:00.000,715.1,727.5,710.0,722.0,420304.0,IPCA Labs shares fall as USFDA issues Form 483 to API unit with 11 observations,IPCA Labs shares fell 2.99 per cent to hit a low of Rs 712.85 on BSE. The stock is down 14 per cent year-to-date against a 6.37 per cent rise in the BSE Pharma index during the same period.,negative,negative,0.964900013984055,positive,1.876731301939052,positive
2023-06-14 18:02:32.000,715.1,727.5,710.0,722.0,420304.0,Ipca shares drop nearly 3% after USFDA’s 11 observations about MP facility,IPCA Labs shares: Company says it takes quality and compliance issues with ‘utmost importance’,negative,neutral,0.964900013984055,positive,1.876731301939052,positive
2023-06-26 05:14:00.000,700.1,744.85,691.2,740.0,2881635.0,"Stocks To Watch: TCS, HDFC Life, IPCA, Rail Vikas Nigam, Axis Bank",Here are the stocks to watch before going into trade today.,neutral,neutral,5.699185830595626,positive,0.1290673187962836,neutral
2023-06-26 06:37:44.000,700.1,744.85,691.2,740.0,2881635.0,"Buzzing Stocks: Ipca Lab, RVNL, Asian Paints, HDFC Life and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,5.699185830595626,positive,0.1290673187962836,neutral
2023-06-26 07:47:30.000,700.1,744.85,691.2,740.0,2881635.0,Ipca Lab may face the heat as USFDA issues Form 483 with 8 observations,"The share touched a 52-week high of Rs 1,033.50 and a 52-week low of Rs 670 on 05 August, 2022 and 22 May, 2023, respectively.",neutral,negative,5.699185830595626,positive,0.1290673187962836,neutral
2023-06-26 08:03:25.000,700.1,744.85,691.2,740.0,2881635.0,"Stocks to Watch, June 26, 2023: IndusInd Bank,Ipca Lab,Infosys, ICICI Securities,HDFC Life | Business Standard","Top Stocks to Watch on June 26, 2023: The Hinduja Group is in talks to invest Rs 10,000 crore to hike its stake in IndusInd Bank, as per media reports",neutral,positive,5.699185830595626,positive,0.1290673187962836,neutral
2023-06-26 09:31:46.000,700.1,744.85,691.2,740.0,2881635.0,Stocks that will see action today (June 26),"Shree Cements, ICICI Securities, ICICI Bank, Aurobindo Pharma, J&K Bank, Godrej Properties, Ipca Lab, Asian Paints, RVNL, Cambridge Tech, AU Small Finance Bank, HDC Life, HDFC and Zydus LifeSciences are the stocks to watch on June 26, 2023",neutral,neutral,5.699185830595626,positive,0.1290673187962836,neutral
2023-06-26 17:30:00.000,736.05,741.0,729.0,737.0,739635.0,"Stocks in news: YES Bank, Grasim, Asian Paints, Rail Vikas Nigam and more","Stocks to watch out for today: YES Bank, Godrej Properties, Ipca Laboratories, Asian Paints, Rail Vikas Nigam, Cambridge Technology Enterprises, AU Small Finance Bank, HDFC Life Insurance Company and more",neutral,neutral,0.1290673187962836,neutral,1.2159500033965147,positive
2023-07-04 13:50:24.000,747.0,753.9,743.05,750.1,215364.0,"Ipca Lab’s Two Facilities May Face Regulatory Action From U.S. FDA, Says Nomura","The inspection found some objectionable conditions at the unit, for which regulatory action should be recommended by the U.S. FDA.",neutral,neutral,0.4149933065595746,neutral,1.3333333333333337,positive
2023-07-27 21:56:34.000,833.35,865.8,825.75,856.1,1092157.0,CCI approves Ipca Laboratories 59.38% stake buy deal in Unichem Laboratories,"CCI approves Ipca Laboratories’ acquisition of up to 59.38% of Unichem Laboratories Ltdimited, subject to compliance of voluntary undertakings. Deal announced in April to acquire 33.38% stake for ₹1,034 crore. Open offer to public to acquire additional 26% stake.",neutral,neutral,2.729945401091978,positive,2.040578358208955,positive
2023-07-28 09:09:31.000,833.35,865.8,825.75,856.1,1092157.0,"Stocks to watch today: July 28, 2023",Adani New Industries raised $394 million from Barclays PLC and Deutsche Bank AG for its solar module manufacturing facility. Ipca Laboratories’ stake purchase in Unichem Laboratories was approved by the Competition Commission. Adani Transmission renamed itself to Adani Energy Solutions. Religare Ent…,neutral,positive,2.729945401091978,positive,2.040578358208955,positive
2023-08-02 09:53:25.000,900.0,904.45,880.35,890.0,1052548.0,Unichem Lab rises over 1% amid block deal announcement,Ipca Labs had informed the exchanges last week of receiving a go ahead from the Competition Commission of India for acquiring a majority stake in Unichem Labs.,positive,neutral,-1.1111111111111112,negative,0.3602792163926966,neutral
2023-08-02 19:05:04.000,888.2,921.9,887.6,891.4,1862675.0,Ipca picks up 33.38% equity in Unichem for ₹945 crore,Ipca Labs acquires 33.38% of Unichem Labs for ₹945 crore. CCI approved the deal in April. Ipca has made an open offer to Unichem’s public shareholders to acquire 26% of the fully diluted equity share capital at ₹440 per share. SEBI’s observations on the DLOF are awaited. Ipca’s share price ended at …,positive,positive,0.3602792163926966,neutral,0.0,neutral
2023-08-02 21:33:49.000,888.2,921.9,887.6,891.4,1862675.0,Bulk Deals | Ipca Labs picks 33.38% stake in Unichem; Madhusudan Kela’s wife buys 5.3% stake in Niyogin,"Though huge buying was seen in Campus Activewear, the stock fell 4.3 percent to Rs 290 amid weak equity market conditions",neutral,negative,0.3602792163926966,neutral,0.0,neutral
2023-08-03 11:03:34.000,888.2,921.9,887.6,891.4,1862675.0,Unichem Labs erases early gains from Ipca deal as profit-booking kicks in,Ipca Laboratories picked 33.38% stake in Unichem Labs after CCI approval.,positive,neutral,0.3602792163926966,neutral,0.0,neutral
2023-08-17 08:03:58.000,889.0,900.95,886.3,889.7,197760.0,Hold Ipca Laboratories; target of Rs 880: Prabhudas Lilladher,"Prabhudas Lilladher recommended hold rating on Ipca Laboratories with a target price of Rs 880 in its research report dated August 13, 2023.",neutral,positive,0.07874015748032,neutral,-1.462922481923654,negative
2023-08-21 21:24:49.000,891.7,896.75,883.35,884.9,263217.0,Trade setup for Tuesday: Top 15 things to know before the opening bell,"Based on the OI percentage, 81 stocks were on the short-covering list. These included ITC, Granules India, Ipca Laboratories, Lupin, and Atul. A decrease in OI along with a price increase is an indication of short-covering.",neutral,neutral,-0.762588314455542,neutral,-0.9159787402465124,negative
2023-08-23 15:09:56.000,889.0,918.75,878.0,887.0,1346243.0,Neutral Ipca Laboratories; target of Rs 840: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 840 in its research report dated August 12, 2023.",neutral,neutral,-0.2249718785151856,neutral,-0.7158962795941402,neutral
2023-08-24 11:08:14.000,889.0,918.75,878.0,887.0,1346243.0,Ipca Laboratories gains 3% on USFDA classification,"The VAI classification, considered the second best, comes after the pharma company’s Piparia facility in Silvassa had undergone US FDA inspection in April.",positive,positive,-0.2249718785151856,neutral,-0.7158962795941402,neutral
